<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
<journal-id journal-id-type="pmc">ploscomp</journal-id><journal-title-group>
<journal-title>PLoS Computational Biology</journal-title></journal-title-group>
<issn pub-type="ppub">1553-734X</issn>
<issn pub-type="epub">1553-7358</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PCOMPBIOL-D-12-01456</article-id>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1002902</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Education</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Computational biology</subject></subj-group></subj-group></article-categories>
<title-group>
<article-title>Chapter 15: Disease Gene Prioritization</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bromberg</surname><given-names>Yana</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><addr-line>Department of Biochemistry and Microbiology, School of Environmental and Biological Sciences, Rutgers University, New Brunswick, New Jersey, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Lewitter</surname><given-names>Fran</given-names></name>
<role>Editors</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>(Whitehead Institute, United States of America), and Maricel Kann (University of Maryland, Baltimore County, United States of America)</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">YanaB@rci.rutgers.edu</email></corresp>
<fn fn-type="conflict"><p>The author has declared that no competing interests exist.</p></fn>
</author-notes>
<pub-date pub-type="collection"><month>4</month><year>2013</year></pub-date>
<pub-date pub-type="epub"><day>25</day><month>4</month><year>2013</year></pub-date>
<volume>9</volume>
<issue>4</issue>
<elocation-id>e1002902</elocation-id><permissions>
<copyright-year>2013</copyright-year>
<copyright-holder>Yana Bromberg</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>Disease-causing aberrations in the normal function of a gene define that gene as a disease gene. Proving a causal link between a gene and a disease experimentally is expensive and time-consuming. Comprehensive prioritization of candidate genes prior to experimental testing drastically reduces the associated costs. Computational gene prioritization is based on various pieces of correlative evidence that associate each gene with the given disease and suggest possible causal links. A fair amount of this evidence comes from high-throughput experimentation. Thus, well-developed methods are necessary to reliably deal with the quantity of information at hand. Existing gene prioritization techniques already significantly improve the outcomes of targeted experimental studies. Faster and more reliable techniques that account for novel data types are necessary for the development of new diagnostics, treatments, and cure for many diseases.</p>
</abstract>
<funding-group><funding-statement>YB is funded by Rutgers, New Brunswick start-up funding, Gordon and Betty Moore Foundation grant, and USDA-NIFA and NJAES grants Project No. 10150-0228906. The funders had no role in the preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="16"/></counts></article-meta>
</front>
<body><sec id="s1">
<title/>
<disp-quote>
<p>This article is part of the “Translational Bioinformatics" collection for <italic>PLOS Computational Biology</italic>.</p>
</disp-quote>
    <boxed-text id="pcbi-1002902-box003" position="float"><sec id="s1a1">
        <title>What to Learn in This Chapter</title>
        <list list-type="bullet"><list-item>
            <p>Identification of specific disease genes is complicated by gene pleiotropy, polygenic nature of many diseases, varied influence of environmental factors, and overlying genome variation.</p>
        </list-item><list-item>
            <p>Gene prioritization is the process of assigning likelihood of gene involvement in generating a disease phenotype. This approach narrows down, and arranges in the order of likelihood in disease involvement, the set of genes to be tested experimentally.</p>
        </list-item><list-item>
            <p>The gene “priority" in disease is assigned by considering a set of relevant features such as gene expression and function, pathway involvement, and mutation effects.</p>
        </list-item><list-item>
            <p>In general, disease genes tend to 1) interact with other disease genes, 2) harbor functionally deleterious mutations, 3) code for proteins localizing to the affected biological compartment (pathway, cellular space, or tissue), 4) have distinct sequence properties such as longer length and a higher number of exons, 5) have more orthologues and fewer paralogues.</p>
        </list-item><list-item>
            <p>Data sources (directly experimental, extracted from knowledge-bases, or text-mining based) and mathematical/computational models used for gene prioritization vary widely.</p>
        </list-item></list>
    </sec></boxed-text></sec><sec id="s2">
<title>1. Introduction</title>
<p>In 1904 Dr. James Herrick reported <xref ref-type="bibr" rid="pcbi.1002902-Herrick1">[1]</xref> the findings of “peculiar elongated and sickle shaped" red blood cells discovered by Dr. Ernest Irons in a hospital patient afflicted with shortness of breath, heart palpitations, and various other aches and pains. This was the first documented case of sickle cell disease in the United States. Forty years later, in 1949, sickle cell anemia became the first disease to be characterized on a molecular level <xref ref-type="bibr" rid="pcbi.1002902-Pauling1">[2]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Ingram1">[3]</xref>. Thus, implicitly, the first disease-associated gene, coding for beta-globin chain of hemoglobin A, was discovered.</p>
<p>It took another thirty years before in 1983 a study of the DNA of families afflicted with Huntington's disease has revealed its association with a gene on chromosome 4 called huntigtin (HTT) <xref ref-type="bibr" rid="pcbi.1002902-Gusella1">[4]</xref>. Huntington's became the first genetic disease mapped using polymorphism information (G8 DNA probe/genetic marker), closely followed by the same year discovery of phenylketonuria association with polymorphisms in a hepatic enzyme phenylalanine hydroxylase <xref ref-type="bibr" rid="pcbi.1002902-Woo1">[5]</xref>. These advances provided a route for predicting the likelihood of disease development and even stirred some worries regarding the possibility of the rise of “medical eugenics" <xref ref-type="bibr" rid="pcbi.1002902-Robertson1">[6]</xref>. Interestingly, it took another ten years for HTT's sequence to be identified and for the precise nature of the Huntigton's-associated mutation to be determined <xref ref-type="bibr" rid="pcbi.1002902-1">[7]</xref>.</p>
<p>The recent explosion in high-throughput experimental techniques has contributed significantly to the identification of disease-associated genes and mutations. For instance, the latest release of SwissVar <xref ref-type="bibr" rid="pcbi.1002902-Yip1">[8]</xref>, a variation centered view of the Swiss-Prot database of genes and proteins <xref ref-type="bibr" rid="pcbi.1002902-UniProt1">[9]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Bairoch1">[10]</xref>, reports nearly 20 thousand mutations in 35 hundred genes associated with over three thousand broad disease classes. Unfortunately, the improved efficiency in production of association data (<italic>e.g.</italic> genome-wide association studies, GWAS) has not been matched by its similarly improving accuracy. Thus, the sheer quantity of existing but yet unvalidated data resulted in information overflow. While association and linkage studies provide a lot of information, incorporation of other sources of evidence is necessary to narrow down the candidate search space. Computational methods - gene prioritization techniques, are therefore necessary to effectively translate the experimental data into legible disease-gene associations <xref ref-type="bibr" rid="pcbi.1002902-Moreau1">[11]</xref>.</p>
</sec><sec id="s3">
<title>2. Background</title>
<p>The Merriam-Webster dictionary defines the word “disease" as a “a condition of the living animal or plant body or of one of its parts that impairs normal functioning and is typically manifested by distinguishing signs and symptoms." Thus, disease is defined <italic>with respect to normal function</italic> of said body or body part. Note, that this definition also describes the malfunction of individual cells or cell groups. In fact, many diseases can and should be defined on a cellular level. Understanding a disease, and potentially finding curative or preventive measures, requires answering three questions: (1) What is the affected function? (2) What functional activity levels are considered normal given the environmental contexts? (3) What is the direction and amount of change in this activity necessary to cause the observed phenotype?</p>
<p>Contrary to the view that historically prevailed in classical genetics it is rarely the case that one gene is responsible for one function. Rather, an assembly of genes constitutes a functional module or a molecular pathway. By definition, a molecular pathway leads to some specific end point in cellular functionality via a series of interactions between molecules in the cell. Alterations in any of the normally occurring processes, molecular interactions, and pathways lead to disease. For example, folate metabolism is an important molecular pathway, the disruptions in which have been associated with many disorders including colorectal cancer <xref ref-type="bibr" rid="pcbi.1002902-Potter1">[12]</xref> and coronary heart disease <xref ref-type="bibr" rid="pcbi.1002902-Frosst1">[13]</xref>. Because this pathway involves 19 proteins interacting via numerous cycles and feedback loops <xref ref-type="bibr" rid="pcbi.1002902-Thomas1">[14]</xref>, it is not surprising that there are a number of different ways in which it can be broken. The changes in concentrations and/or activity levels of any of the pathway members directly affect the pathway end-products (<italic>e.g.</italic> pyrimidine and/or methylated DNA). The specifics of a given change define the severity and the type of the resulting disease; see <xref ref-type="sec" rid="pcbi-1002902-box001">Box 1</xref> for discussion on disease types. Moreover, since the view of a single pathway as a discrete and independent entity (with no overlap with other pathways) is an oversimplification, it is increasingly evident that different diseases are also interdependent.</p>
<boxed-text id="pcbi-1002902-box001" position="float"><sec id="s3a1">
<title>Box 1. Genetic similarities of different disease types</title>
<p>Diseases can be very generally classified by their associated causes: <italic>pathogenic</italic> (caused by an infection), <italic>environmentally determined</italic> (caused by “inanimate" environmental stressors and deficiencies, such as physical trauma, nutrient deficiency, radiation exposure and sleep deprivation), and <italic>genetically hereditary</italic> or <italic>spontaneous</italic> (defined by germline mutations and spontaneous errors in DNA transcription, respectively). Moreover, certain genotypes are more susceptible to the effects of pathogens and environmental stress, contributing to a deadly interplay between disease causes. Regardless of the cause of disease, its manifestations are defined by the changes in the affected function. For example, cancer is the result of DNA damage occurring in a normal cell and leading toward a growth and survival advantage. The initial damage is generally limited to a fairly small number of mutations in key genes, such as proto-oncogenes and tumor suppressor genes <xref ref-type="bibr" rid="pcbi.1002902-Sarasin1">[135]</xref>. The method of accumulation of these mutants is not very important. A viral infection may cause cancer by enhancing proto-oncogene function <xref ref-type="bibr" rid="pcbi.1002902-Parsonnet1">[136]</xref> or by inserting viral oncogenes into host cell genome. An inherited genetic variant may disrupt or silence a single allele of a mismatch-repair gene as in Lynch syndrome <xref ref-type="bibr" rid="pcbi.1002902-Hitchins1">[137]</xref>. Spontaneous transcription errors and influence of environmental factors, <italic>e.g.</italic> continued exposure to high levels of ionizing radiation, may result in oncogene and tumor suppressor-gene mutations leading to the development of cancer <xref ref-type="bibr" rid="pcbi.1002902-Williams1">[138]</xref>. Thus, the same broad types of disease can be caused by the disruption of the same mechanisms or pathways resulting from any of the three types of causes.</p>
</sec></boxed-text></sec><sec id="s4">
<title>3. Interpreting What We Know</title>
<p>Identifying the genetic underpinnings of the observed disease is a major challenge in human genetics. Since disease results from the alteration of normal function, identifying disease genes requires defining molecular pathways whose disrupted functionality is necessary and sufficient to cause the observed disease. The pathway function changes due to the (1) changes in gene expression (<italic>i.e.</italic> quantity and concentration of product), (2) changes in structure of the gene-product (<italic>e.g.</italic> conformational change, binding site obstruction, loss of ligand affinity, etc.), (3) introduction of new pathway members (<italic>e.g.</italic> activation of previously silent genes), and (4) environmental disruptions (<italic>e.g.</italic> increased temperatures due to inflammation or decreased ligand concentrations due to malnutrition). While all members of the affected pathways can be construed as disease genes, the identification of a subset of the true causative culprits is difficult. Obscuring such identification are individual genome variation (<italic>i.e.</italic> the reference definition of “normal" is person-specific), multigenic nature and complex phenotypes of most diseases, varied influence of environmental factors, as well as experimental data heterogeneity and constraints.</p>
<p>Disease genes are most often identified using: (1) genome wide association or linkage analysis studies, (2) similarity or linkage to and co-regulation/co-expression/co-localization with known disease genes, and (3) participation in known disease-associated pathways or compartments. In bioinformatics, these are represented by multiple sources of evidence, both direct, <italic>i.e.</italic> evidence coming from own experimental work and from literature, and indirect, <italic>i.e.</italic> “guilt-by-association" data. The latter means that genes that are in any way related to already established disease-associated genes are promoted in the suspect list. Additionally, implied gene-disease links, such as functional deleteriousness of mutations affecting candidate genes, contributes to establishing associations. The manner in which each guilty association is derived varies from tool to tool and all of them deserve consideration. Very broadly, gene-disease associations are inferred from (<xref ref-type="fig" rid="pcbi-1002902-g001">Figure 1</xref>):</p>
<fig id="pcbi-1002902-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1002902.g001</object-id><label>Figure 1</label><caption>
<title>Overview of gene prioritization data flow.</title>
<p>In order to prioritize disease-gene candidates various pieces of information about the disease and the candidate genetic interval are collected (green layer). These describe the biological relationships and concepts (blue layer) relating the disease to the possible causal genes. Note, the blue layer (representing the biological meaning) should ideally be blind to the content green layer (information collection); <italic>i.e.</italic> any resource that describes the needed concepts may be used by a gene prioritization method.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002902.g001" position="float" xlink:type="simple"/></fig>
<list list-type="order"><list-item>
<p><italic>Functional Evidence</italic> – the suspect gene is a member of the same molecular pathways as other disease-genes; inferred from: direct molecular interactions, transcriptional co-(regulation/expression/localization), genetic linkage, sequence/structure similarity, and paralogy (in-species homology resulting from a gene duplication event)</p>
</list-item><list-item>
<p><italic>Cross-species Evidence</italic> – the suspect gene has homologues implicated in generating similar phenotypes in other organisms</p>
</list-item><list-item>
<p><italic>Same-compartment Evidence</italic> – the suspect gene is active in disease-associated pathways (<italic>e.g.</italic> ion channels), cellular compartments (<italic>e.g.</italic> cell membrane), and tissues (<italic>e.g.</italic> liver).</p>
</list-item><list-item>
<p><italic>Mutation Evidence</italic> – suspect genes are affected by functionally deleterious mutations in genomes of diseased individuals</p>
</list-item><list-item>
<p><italic>Text Evidence</italic> – there is ample co-occurrence of gene and disease terms in scientific texts. Note that textual co-occurrence represents some form of biological evidence, which does not yet lend itself to explicit documentation.</p>
</list-item></list>
<sec id="s4a">
<title>3.1 Functional Evidence</title>
<sec id="s4a1">
<title>3.1.1 Molecular interactions</title>
<p>Gene prioritization tools, from the earliest field pioneers like G2D <xref ref-type="bibr" rid="pcbi.1002902-PerezIratxeta1">[15]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-PerezIratxeta2">[16]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-PerezIratxeta3">[17]</xref> to the more recent ENDEAVOUR <xref ref-type="bibr" rid="pcbi.1002902-Tranchevent1">[18]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Tranchevent2">[19]</xref> and GeneWanderer <xref ref-type="bibr" rid="pcbi.1002902-Kohler1">[20]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Kohler2">[21]</xref>, among many others, have used gene-gene (protein-protein) interaction and/or pathway information to prioritize candidate genes. Biologically this makes sense, because if diseases result from pathway breakdown then disabling any of the pathway components can produce similar phenotypes; <italic>i.e.</italic> genes responsible for similar diseases often participate in the same interaction networks <xref ref-type="bibr" rid="pcbi.1002902-Sun1">[22]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Gandhi1">[23]</xref>. To illustrate this point, consider the interaction partners of the melanocortin 4 receptor (MC4R) in STRING <xref ref-type="bibr" rid="pcbi.1002902-Jensen1">[24]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Snel1">[25]</xref> server generated <xref ref-type="fig" rid="pcbi-1002902-g002">Figure 2</xref>. Note, not all known interactions are shown – the inclusion parameter is STRING server likelihood &gt;0.9.</p>
<fig id="pcbi-1002902-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1002902.g002</object-id><label>Figure 2</label><caption>
<title>MC4R-centered protein-protein interaction network.</title>
<p>The figure illustrates protein-protein interaction neighborhood of the human melanocortin 4 receptor (MC4R) as illustrated by the confidence view of the STRING 8.3 server. The nodes of the graph represent human proteins and the connections illustrate their known or predicted, direct and indirect interactions. The connection between any two protein-nodes is based on the available information mined from relevant databases and literature. The network includes all protein interactions that have &gt;0.9 estimated probability.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002902.g002" position="float" xlink:type="simple"/></fig>
<p>MC4R is a hypothalamic receptor with a primary function of energy homeostasis and food intake regulation. Functionally deleterious polymorphisms in this receptor are known to be associated with severe obesity <xref ref-type="bibr" rid="pcbi.1002902-Huszar1">[26]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-LubranoBerthelier1">[27]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Farooqi1">[28]</xref>. Here, MC1R, MC3R, and MC5R are membrane bound melanocortin (1,3,5) receptors that interact with MC4R via shared binding partners. Syndecan-3 (SDC3), agouti signaling protein precursor (ASIP), agouti related protein precursor (AgRP), pro-opiomelanocortin (POMC) and/or their processed derivatives directly bind MC4R for varied purposes of the MC4R signaling pathway. Finally, the reported interactions with Neuropeptide Y-precursor (NPY) and the growth hormone releasing protein (GHRL) are literature derived and may reflect indirect, but tight connectivity. By the token of “same pathway" evidence, <italic>MC4R</italic> interactors, whether agonists or antagonists, may be predicted to be linked to obesity. In fact, mutations that negatively affect normal POMC production or processing have been shown to be obesity-associated <xref ref-type="bibr" rid="pcbi.1002902-Challis1">[29]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Yaswen1">[30]</xref> and gene association studies have linked AgRP with anorexia and bulimia nervosa behavioral traits <xref ref-type="bibr" rid="pcbi.1002902-Helder1">[31]</xref>, representative of food intake abnormalities. Other pathway participants have also been marked and extensively studied for obesity association.</p>
</sec><sec id="s4a2">
<title>3.1.2 Regulatory and genetic linkage</title>
<p>Co-regulation of genes has traditionally been thought to point to their involvement in same molecular pathways <xref ref-type="bibr" rid="pcbi.1002902-vanNoort1">[32]</xref> and, by that token, to similar disease phenotypes; <italic>e.g.</italic> <xref ref-type="bibr" rid="pcbi.1002902-Huang1">[33]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Jesmin1">[34]</xref>. For example, GPR30 a novel G-protein coupled estrogen receptor is co-expressed with the classical estrogen receptor ERβ <xref ref-type="bibr" rid="pcbi.1002902-Huang1">[33]</xref>. The former (GPR30) has been linked to endometrial carcinoma <xref ref-type="bibr" rid="pcbi.1002902-Smith1">[35]</xref> so it is no surprise that the latter (ERβ) is also associated with this type of cancer <xref ref-type="bibr" rid="pcbi.1002902-Huang1">[33]</xref>.</p>
<p>However, co-regulation doesn't <italic>always</italic> have to mean the same pathway – studies have shown that consistently co-expressed genes, while possibly genetically linked <xref ref-type="bibr" rid="pcbi.1002902-Elizondo1">[36]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Spellman1">[37]</xref>, may also reside in distinct pathways <xref ref-type="bibr" rid="pcbi.1002902-Yu1">[38]</xref>. Additionally, co-expressed non-paralogous genes, independent of common pathway involvement, often cluster together in different species and fall into chromosomal regions with low recombination rates <xref ref-type="bibr" rid="pcbi.1002902-Singer1">[39]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Hurst1">[40]</xref>, suggesting genetic linkage <xref ref-type="bibr" rid="pcbi.1002902-Singer1">[39]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Hurst1">[40]</xref>. These finding suggests that clusters of co-expressed genes are selectively advantageous <xref ref-type="bibr" rid="pcbi.1002902-Elizondo1">[36]</xref>. Possibly, these clusters are groups of genes that despite the apparent functional heterogeneity may be jointly involved in orchestrating complicated cellular functionality <xref ref-type="bibr" rid="pcbi.1002902-Dawkins1">[41]</xref>. Evolutionary pressure works on maintaining co-expression of these genes and on keeping recombination rates within the clusters low. Thus, the fine-tuned cooperation of alleles is not broken by recombination, but rather transmitted as one entity to the next generation. De-regulation of these clusters is therefore likely to be deleterious to the organism and develop into disease.</p>
<p>Genes co-expressed with or genetically linked to other disease genes are also likely to be disease-associated. However, while genetic linkage and co-regulation are valuable markers of disease association, they also pose a specificity problem; <italic>i.e.</italic> a given disease-associated gene may be co-regulated with or linked to another disease-associated gene, where the two diseases are not identical. Genetic linkage similarly poses a problem for GWAS where it is difficult to distinguish between “driver" mutations, the actual causes of disease, and “passenger" mutations, co-occurring with the disease-mutations due to genetic linkage.</p>
</sec><sec id="s4a3">
<title>3.1.3 Similar sequence/structure/function</title>
<p>Reduced or absent phenotypic effect in response to gene knockout/inactivation is a common occurrence <xref ref-type="bibr" rid="pcbi.1002902-Gu1">[42]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Conant1">[43]</xref>, largely explained by functional compensation, <italic>i.e.</italic> partial interchangeability of paralogous genes. In humans, genes with at least one paralogue, approximated by 90% sequence identity, are about three times less likely to be associated with disease as compared to genes with more remote homologs <xref ref-type="bibr" rid="pcbi.1002902-Hsiao1">[44]</xref>. However, in the cases where paralogous functional compensation is insufficient to restore normal function, inactivation of any of the paralogues leads to same or similar disease. Prioritization tools thus often use functional similarity as an input feature. For example, one GeneOntology (GO, <xref ref-type="bibr" rid="pcbi.1002902-Ashburner1">[45]</xref>) defined MC4R function, is “melanocyte-stimulating hormone receptor activity" (GO:0004980). There are two other human gene products sharing this function: MSHR (MC1R, 52% sequence identity) and MC3R (61%). Predictors relying on functional similarity to annotate disease association would inevitably link both of these with obesity. These findings are confirmed by the recent studies for MC3R <xref ref-type="bibr" rid="pcbi.1002902-Mencarelli1">[46]</xref>, but the jury still remains out for MC1R involvement.</p>
<p>Quantifying functional similarity is of utmost importance for the above approach. Using ontology-defined functions (<italic>e.g.</italic> GeneOntology) this problem reduces to finding a distance between two ontology nodes/subtrees (<italic>e.g.</italic> <xref ref-type="bibr" rid="pcbi.1002902-Lord1">[47]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Wang1">[48]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-delPozo1">[49]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Schlicker1">[50]</xref>). For un-annotated genes, however, sequence and structure homology is often used to transfer functional annotations from studied genes and proteins <xref ref-type="bibr" rid="pcbi.1002902-Punta1">[51]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Rentzsch1">[52]</xref>. Since functionally similar genes are likely to produce similar disease phenotypes, sequence/structure similarities are good indicators of similar disease involvement. Additionally, disease genes are often associated with specific gene and protein features such as higher exon number and longer gene length, protein length, presence of signal peptides, higher distance to a neighboring gene and 3′ UTR length, and lower sequence divergence from their orthologues <xref ref-type="bibr" rid="pcbi.1002902-LopezBigas1">[53]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Adie1">[54]</xref>. Moreover, disordered proteins are often implicated in cancer <xref ref-type="bibr" rid="pcbi.1002902-Iakoucheva1">[55]</xref>.</p>
</sec></sec><sec id="s4b">
<title>3.2 Cross-species Evidence</title>
<p>Animal models exist for a broad range of human diseases in a number of well-studied laboratory organisms, <italic>i.e.</italic> mouse, zebrafish, fruit fly, etc. However, straightforward cross-species comparisons of orthologues and their associated phenotypic traits are also very useful. A high number of orthologues (consistent presence in multiple species) generally highlights essential genes that are prone to disease involvement. Orthologues generally participate in similar molecular pathways although different levels of function are necessary for different organisms (<italic>e.g.</italic> human MC4R is more functional then its polar bear orthologue <xref ref-type="bibr" rid="pcbi.1002902-Staubert1">[56]</xref>). Thus, cross-species tissue-specific phenotypic differentiation due to slightly varied sequences may be useful for gene prioritization. For example, the human MC4R and almost all of its close orthologues (<italic>e.g.</italic> in mouse, rat, pig, and cow) contain a conserved valine residue in the 95<sup>th</sup> position of the amino acid sequence. In the polar bear orthologue, however, this position is frequently occupied by an isoleucine residue <xref ref-type="bibr" rid="pcbi.1002902-Staubert1">[56]</xref>. When considering MC4R involvement in generating an obesity phenotype, it is useful to note that polar bears have a need for increased body fat content for thermal insulation, water buoyancy, and energy storage requirements <xref ref-type="bibr" rid="pcbi.1002902-Staubert1">[56]</xref> as compared to humans and to other organisms that share a conserved V95. Thus, one can imagine that the V95I mutation, while deleterious to the function of the receptor, is a polar bear specific adaptation to its environment, and may have a similar (increased body fat) effect in humans. In fact, V95I does inactivate the human receptor <xref ref-type="bibr" rid="pcbi.1002902-Xiang1">[57]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Hinney1">[58]</xref> and associates with obesity.</p>
<p>Comparing human and animal phenotypes is not always straightforward. Washington <italic>et al</italic> <xref ref-type="bibr" rid="pcbi.1002902-Washington1">[59]</xref> have shown that phenotype ontologies facilitate genotype-phenotype comparisons across species. Disease phenotypes recorded in their ontology (OBD, ontology based database) can be compared to the similarly built cross-species phenotype ontologies using a set of proposed similarity metrics. Finding related phenotypes across species suggests orthologous human candidate genes. For instance, phenotypic similarities of eye abnormalities recorded in human and fly suggest that <italic>PAX6</italic>, a human orthologue of the phenotype-associated fly gene <italic>ey</italic>, is a possible disease-gene candidate. Further investigation shows that mutations in <italic>PAX6</italic> may result in aniridia (absence of iris), corneal opacity (aniridia-related keratopathy), cataract (lens clouding), glaucoma, and long-term retinal degeneration (<xref ref-type="fig" rid="pcbi-1002902-g003">Figure 3</xref>) <xref ref-type="bibr" rid="pcbi.1002902-Washington1">[59]</xref>.</p>
<fig id="pcbi-1002902-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1002902.g003</object-id><label>Figure 3</label><caption>
<title>Correlating cross-species phenotypes.</title>
<p>Phenotypes of wild-type (top) and PAX6 ortholog mutations (bottom) in human, mouse, zebrafish, and fly can be described with the EQ method suggested by Washington et al <xref ref-type="bibr" rid="pcbi.1002902-Washington1">[59]</xref>. Once phenotypic descriptions are standardized across species, genotypic variations can be assessed as well.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002902.g003" position="float" xlink:type="simple"/></fig>
<p>A correlation of gene co-expression across species is also useful for annotating disease genes <xref ref-type="bibr" rid="pcbi.1002902-Mootha1">[60]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Ala1">[61]</xref>. Genes that are part of the same functional module are generally co-expressed. Also, there is evidence for co-expression of visibly functionally unrelated genes <xref ref-type="bibr" rid="pcbi.1002902-Spellman1">[37]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Michalak1">[62]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Fukuoka1">[63]</xref>. The explanation of these co-expression clusters having an evolutionary advantage only holds true for otherwise unjustified conservation of these clusters throughout different species; <italic>i.e.</italic> cross-species comparison of protein co-expression may be used for validation of disease-gene co-expression inference. Using this assumption, Ala <italic>et al</italic> <xref ref-type="bibr" rid="pcbi.1002902-Ala1">[61]</xref> had narrowed down the initial list of 1,762 genes in the loci mapped via genetic linkage to 850 OMIM (Online Mendelian Inheritance in Man) <xref ref-type="bibr" rid="pcbi.1002902-McKusickNathans1">[64]</xref> phenotypes to twenty times fewer (81) possible disease-causing genes. For example, in their analysis a cluster of functionally unrelated genes co-expressed in human and mouse contained a <italic>bona fide</italic> disease-gene KCNIP4 (partial epilepsy with pericentral spikes).</p>
</sec><sec id="s4c">
<title>3.3 Compartment Evidence</title>
<p>Changes in gene expression in disease-affected tissues are associated with many complex diseases <xref ref-type="bibr" rid="pcbi.1002902-Stranger1">[65]</xref>. Tissue specificity is also important for choosing correct protein-protein interaction networks, as some proteins interact in some tissues, but rarely in others <xref ref-type="bibr" rid="pcbi.1002902-Jiang1">[66]</xref>. Disease-associated cellular pathways (<italic>e.g.</italic> ion channels or endocytic membrane transport) and compartments (<italic>e.g.</italic> membrane or nucleus) implicate pathway/compartment-specific gene-products in disease as well. For example, autosomal recessive generalized myotonia (Becker's disease) (GM) and autosomal dominant myotoniacongenita (Thomsen's disease, MC) are characterized by skeletal muscle stiffness <xref ref-type="bibr" rid="pcbi.1002902-Koch1">[67]</xref>. This phenotype is the result of muscle membrane hyperexcitability and, in conjunction with observed alterations in muscle chloride and sodium currents, points to possible involvement of deficiencies of the muscle chloride channel. In fact, studies point to the mutations in the transmembrane region of CLC-1, the muscle chloride channel coding gene, as the culprit <xref ref-type="bibr" rid="pcbi.1002902-Koch1">[67]</xref>. Another example is that of the multiple storage diseases, such as Tay-Sachs, Gaucher, Niemann-Pick and Pompe disease, which are caused by the impairment of the degradation pathways of the intracellular vesicular transport. In fact, many of the genes implicated in these diseases encode for proteins localized to endosomes (<italic>e.g. NPC1</italic> in Neimann-Pick <xref ref-type="bibr" rid="pcbi.1002902-Greer1">[68]</xref>) or lysosomes (<italic>e.g. GBA</italic> <xref ref-type="bibr" rid="pcbi.1002902-Liou1">[69]</xref> in Gaucher, <italic>GAA</italic> in Pompe <xref ref-type="bibr" rid="pcbi.1002902-Shieh1">[70]</xref> and <italic>HEXA</italic> in Tay Sachs <xref ref-type="bibr" rid="pcbi.1002902-Lau1">[71]</xref>).</p>
</sec><sec id="s4d">
<title>3.4 Mutant Evidence</title>
<p>By definition, every genetic disease is associated with some sort of mutation that alters normal functionality. In fact, primary selection of candidates for further analysis is often largely based on observations of polymorphisms in diseased individuals, which are absent in healthy controls (<italic>e.g.</italic> GWAS). However, not all observed polymorphisms are associated with deleterious effects. Note, that on average gain and loss of function mutations are considered to alter normal functionality equally deleteriously. Most of the observed variation does not at all manifest phenotypically, some is weakly deleterious with respect to normal function, and less still is weakly beneficial. In nature strongly beneficial mutations are very rare; they spread rapidly in the population and cannot be considered disease-associated. On the other hand, strongly deleterious or inactivating mutations are often incompatible with life. A small percentage of mutations of this type, affecting genes whose function is not life-essential, are often associated with monogenic Mendelian disorders. Strongly deleterious mutations in the genes whose function may somehow be compensated (<italic>e.g.</italic> via paralogue activity) are associated with complex disorders, where the level of compensation affects the observed phenotype. Complex disorders may also accumulate weakly deleterious mutations to generate a strongly negative phenotype. Intuitively it is clear that a selected candidate gene, carrying a deleterious mutation in an affected individual is more likely to be disease-associated than one which contains functionally neutral mutants or no variation at all.</p>
<sec id="s4d1">
<title>3.4.1 Structural variation</title>
<p>Structural variation (SV) is the least studied of all types of mutations. It has long been assumed that less than 10% of human genetic variation is in the form of genome structural variants (insertions and deletions, inversions, translocations, aneuploidy, and copy number variations - CNVs). However, because each of the structural variants is large (kb-Mb scale), the total number of base pairs affected by SVs may actually be comparable to the number of base pairs affected by the much more common SNPs (single nucleotide polymorphisms). Moreover, high throughput detection of structural variants is notoriously difficult and is only now becoming possible with better sequencing techniques and CNV arrays. Thus, more SVs may be discovered in the near future. We do not currently know what proportion of genetic disease is caused by SVs, but we suspect that it is high.</p>
<p>Due to the above mentioned constraints on SV identification, there are only ∼180 thousand structural variants reported in one of the most complete mutation collections – the Database of Genomic Variants, DGV <xref ref-type="bibr" rid="pcbi.1002902-Iafrate1">[72]</xref>. Gross changes to genome sequence are very likely to be disease associated, but also frequently gene non-specific. For instance, Down's syndrome, trisomy 21, is an example of a whole extra chromosome gain and <italic>cri du chat</italic> syndrome results from the deletion of the short arm of chromosome 5 <xref ref-type="bibr" rid="pcbi.1002902-Chen1">[73]</xref>. All of the genes found in these regions of the genome are, by default, associated with the observed disease but neither can be considered primarily causal. When the damage is less extensive the genes involved may be further evaluated for causation. For instance, several epilepsy-associated genes are known, but functionally-significant mutations in these account for only a small fraction of observed disease cases. One study <xref ref-type="bibr" rid="pcbi.1002902-Mefford1">[74]</xref> reports that CNV mutants found in epileptic individuals but not in the general population account for nearly nine percent of all cases. Among these are CNVs resulting from deletions in AUTS2 and CNTNAP2 genes. Both of these genes have been implicated in other neurological disorders <xref ref-type="bibr" rid="pcbi.1002902-Kalscheuer1">[75]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Alarcon1">[76]</xref> reaffirming the possible disease link. Inversions, translocations and large deletions and insertions have all been implicated in different forms of disease. Even very small indels, resulting in an open-reading frame shift (frameshift mutations), are often sufficient to cause disease. For instance, one of the causes of Tay-Sachs is a deletion of a single cytosine nucleotide in the coding sequence of a lysosomal enzyme beta-hexosaminidase <xref ref-type="bibr" rid="pcbi.1002902-Lau1">[71]</xref>.</p>
<p>In most cases of diseases that are associated with SVs the prioritization of disease-causing genes is reduced to finding those that are directly affected by the mutation. Lots of work has been done in this direction, including development of the CNVinetta package <xref ref-type="bibr" rid="pcbi.1002902-Wittig1">[77]</xref> for mining and visualizing CNVs, GASV approach for identifying structural variation boundaries more precisely <xref ref-type="bibr" rid="pcbi.1002902-Sindi1">[78]</xref>, and software created by Ritz <italic>et al</italic> for searching for structural variants in strobe sequencing data <xref ref-type="bibr" rid="pcbi.1002902-Ritz1">[79]</xref>. SV identification is still a new field, but the advances in methodologies will have a great impact on our understanding and study of many of the known diseases.</p>
</sec><sec id="s4d2">
<title>3.4.2 Nucleotide polymorphisms</title>
<p>The other ∼90% of human variation exists in the form of SNPs (single nucleotide polymorphisms) and MNPs (multi-nucleotide polymorphisms; consecutive nucleotide substitutions, usually of length two or three). A single human genome is expected to contain roughly 10–15 million SNPs per person <xref ref-type="bibr" rid="pcbi.1002902-Botstein1">[80]</xref>. As many as 93% of all human genes contain at least one SNP and 98% of all genes are in the vicinity (∼5 kb) of a SNP <xref ref-type="bibr" rid="pcbi.1002902-Chakravarti1">[81]</xref>. The latest release of NCBI dbSNP database <xref ref-type="bibr" rid="pcbi.1002902-Sherry1">[82]</xref> (build 137) contains nearly 43 million validated human SNPs, 17.5 million of which have been experimentally mapped to functionally distinct regions of the genome (<italic>i.e.</italic> mRNA UTR, intron, or coding regions). Non-coding region SNPs (∼17.2 million) are trivially more prevalent than coding SNPs (∼432 thousand) as non-coding DNA makes up the vast majority of the genome. Coding SNPs, however, are over-represented in disease associations; <italic>e.g.</italic> OMIM contains 2430 non-coding SNPs (0.0001% of all) and 5327 coding ones (0.01% of all – 100-fold enrichment). Due to the redundancy of the genetic code, coding SNPs can be further subdivided into synonymous (no effect on protein sequence) and non-synonymous (single amino acid substitution) SNPs. Simple statistics of the genetic code suggest that synonymous SNPs should account for 24% of all coding-region SNPs. dbSNP data suggests an even larger percentage of synonymity – ∼188 thousand (44%), which is possibly due to evolutionary pressure eliminating functionally deleterious non-synonymous SNPs. MNPs are rare as compared to SNPs, but are over-represented amongst the protein altering variants, almost always changing the affected amino acid, or two neighboring ones, or introducing a nonsense mutation (stop-codon) <xref ref-type="bibr" rid="pcbi.1002902-Rosenfeld1">[83]</xref>.</p>
<p>Identifying and annotating functional effects of SNPs and MNPs is important in the context of gene prioritization because genes selected for further disease-association studies are more likely to contain a deleterious mutation or be under the control of one (<italic>e.g.</italic> mutations affecting transcription factor or microRNA binding sites). In recent years a number of methods were created for identifying mutations as functionally deleterious. PromoLign <xref ref-type="bibr" rid="pcbi.1002902-Zhao1">[84]</xref>, PupaSNP finder <xref ref-type="bibr" rid="pcbi.1002902-Conde1">[85]</xref>, and RAVEN <xref ref-type="bibr" rid="pcbi.1002902-Andersen1">[86]</xref> look for SNPs affecting transcription, SNPper <xref ref-type="bibr" rid="pcbi.1002902-Riva1">[87]</xref> finds and annotates SNP locations, conservation, and possible functionalities so that they can be visually assessed, and SNPselector <xref ref-type="bibr" rid="pcbi.1002902-Xu1">[88]</xref> and FASTSNP <xref ref-type="bibr" rid="pcbi.1002902-Yuan1">[89]</xref> assess various SNP features such as whether it alters the binding site of a transcription factor, affects the promoter/regulatory region, damages the 3′ UTR sequence that may affect post-transcriptional regulation, or eliminates a necessary splice site. Coding synonymous SNPs have recently been shown to have the same chance of being involved in a disease mechanism as non-coding SNPs <xref ref-type="bibr" rid="pcbi.1002902-Chen2">[90]</xref>. This effect may be due to codon usage bias or to changes in splicing or miRNA binding sites <xref ref-type="bibr" rid="pcbi.1002902-Parmley1">[91]</xref>. However, few (if any) computational methods are able make predictions with regard to their functional effects.</p>
<p>Non-synonymous SNPs are somewhat more studied. Early termination of the protein is very often associated with disease so genes with nonsense mutants are automatically moved up in the list of possible suspects. Missense SNPs and MNPs, which alter the protein sequence without destroying it, may or may not be disease associated. In fact, most methods estimate that only 25–30% of the nsSNPs negatively affect protein function <xref ref-type="bibr" rid="pcbi.1002902-Ng1">[92]</xref>. Databases like OMIM <xref ref-type="bibr" rid="pcbi.1002902-Amberger1">[93]</xref>, and more explicitly, SNPdbe <xref ref-type="bibr" rid="pcbi.1002902-Schaefer1">[94]</xref>, SNPeffect <xref ref-type="bibr" rid="pcbi.1002902-Reumers1">[95]</xref>, PolyDoms <xref ref-type="bibr" rid="pcbi.1002902-Jegga1">[96]</xref>, <email xlink:type="simple">Mutation@A</email> Glance <xref ref-type="bibr" rid="pcbi.1002902-Hijikata1">[97]</xref> and DMDM <xref ref-type="bibr" rid="pcbi.1002902-Peterson1">[98]</xref> map SNPs to known structural/functional effects and diseases. Computational tools that make predictions about functional and disease-associated effects of SNPs include SNAP <xref ref-type="bibr" rid="pcbi.1002902-Bromberg1">[99]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Bromberg2">[100]</xref>, SIFT <xref ref-type="bibr" rid="pcbi.1002902-Kumar1">[101]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Ng2">[102]</xref>, PolyPhen <xref ref-type="bibr" rid="pcbi.1002902-Ramensky1">[103]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Adzhubei1">[104]</xref>, PHD-SNP <xref ref-type="bibr" rid="pcbi.1002902-Capriotti1">[105]</xref>, SNPs3D <xref ref-type="bibr" rid="pcbi.1002902-Yue1">[106]</xref>, and many others. Most of these methods are binary in essence – that is they point to a deficiency without suggesting specifics of the disease or molecular mechanisms of functional failure. Nevertheless, they are very useful in conjunction with other data described above. The recent trend in mutation analysis has seen the development of tools, like SNPNexus <xref ref-type="bibr" rid="pcbi.1002902-Chelala1">[107]</xref> and SNPEffectPredictor <xref ref-type="bibr" rid="pcbi.1002902-McLaren1">[108]</xref> that are no longer limited by DNA type and predict effects for both non-coding and coding region SNPs.</p>
</sec></sec><sec id="s4e">
<title>3.5 Text Evidence</title>
<p>The body of science that addresses gene-disease associations has been growing in leaps and bounds since the mapping of a hemoglobin mutation to sickle cell anemia. Some researchers have been proactive in making their data computationally available from databases like dbSNP, GAD <xref ref-type="bibr" rid="pcbi.1002902-Becker1">[109]</xref>, COSMIC <xref ref-type="bibr" rid="pcbi.1002902-Forbes1">[110]</xref>, <italic>etc</italic>. Others have contributed by depositing knowledge obtained through reading and manual curation into the likes of PMD <xref ref-type="bibr" rid="pcbi.1002902-Kawabata1">[111]</xref>, GeneRIF <xref ref-type="bibr" rid="pcbi.1002902-Mitchell1">[112]</xref> and UniProt <xref ref-type="bibr" rid="pcbi.1002902-UniProt1">[9]</xref>. However, huge amounts of data, which could potentially improve the performance of any gene prioritization method, remains hidden in plain site in natural language text of scientific publications. Consider, for example, a scientist who is interested in prioritizing breast cancer genes. A casual search in PubMed for the term combination <italic>breast cancer</italic> generates over two hundred thousand matches. Limiting the field to <italic>genetics of breast cancer</italic> reduces the count to slightly fewer than fifty thousand. The past thirty days have brought about 46 new papers. Thus, someone interested in getting all the genetic information out of the PubMed collection would need to dedicate his or her life to reading. Fortunately, scientific text mining tools have recently come of age <xref ref-type="bibr" rid="pcbi.1002902-Hirschman1">[113]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Altman1">[114]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Blaschke1">[115]</xref>. The new tools will allow for intelligent identification of possible gene-gene and disease-gene correlations <xref ref-type="bibr" rid="pcbi.1002902-Laurila1">[116]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Caporaso1">[117]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Mika1">[118]</xref>. For example, the Information Hyperlinked Over Proteins, IHOP method <xref ref-type="bibr" rid="pcbi.1002902-Hoffmann1">[119]</xref> links gene/protein names in scientific texts via associated phenotypes and interaction information. For automated link extraction, however, the existing gene prioritization techniques rely mostly on term co-occurrence statistics (<italic>e.g.</italic> PosMed <xref ref-type="bibr" rid="pcbi.1002902-Thornblad1">[120]</xref> and GeneDistiller <xref ref-type="bibr" rid="pcbi.1002902-Seelow1">[121]</xref>) and gene-function annotations (<italic>e.g.</italic> ENDEAVOR <xref ref-type="bibr" rid="pcbi.1002902-Aerts1">[122]</xref> and PolySearch <xref ref-type="bibr" rid="pcbi.1002902-Cheng1">[123]</xref>), which can then be related to diseases as described above.</p>
<p>For a significantly oversimplified example of this type of processing consider searching PubMed for the terms <italic>breast cancer</italic> and <italic>BRCA1</italic>. The initial search returns 50 articles, as compared to 21 for <italic>breast cancer</italic> with <italic>BRCA2</italic>, 6 with <italic>PIK3CA</italic>, 1 with <italic>TOX3</italic>, and 0 for <italic>MC4R</italic> or <italic>CLC1</italic> associations. While the number of publications reflects many extraneous factors such as the popularity and “research age" of the protein, it is also very much reflective of the possibility of gene-disease association. Thus, BRCA1 and BRCA2 would be the most likely candidates for cancer association, followed by PIK3CA and TOX3. MC4R and CLC1 would not make the cut. Note that PubMed now defaults to a smart search engine, which identifies all aliases of the gene and the disease while cutting out more promiscuous matches; <italic>i.e.</italic> turning off the translation of terms would result in significantly more less accurate matches. Using specialized tools like PolySearch (or IHOP) to perform the same queries produces more refined and quantifiable results (<xref ref-type="fig" rid="pcbi-1002902-g004">Figure 4</xref>).</p>
<fig id="pcbi-1002902-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1002902.g004</object-id><label>Figure 4</label><caption>
<title>PolySearch gene-disease associations.</title>
<p>PolySearch uses PubMed lookup results to prioritize diseases associated with a given gene. Here, screen shots of the top two results (where available; sorted by relevancy score metric) from PolySearch are shown. According to these, BRCA1 and PIK3CA are associated with breast cancer, while MC4R and CLC1 are not. These results quantitatively confirm intuitive inferences made from simple PubMed searches.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002902.g004" position="float" xlink:type="simple"/></fig></sec></sec><sec id="s5">
<title>4. The Inputs and Outputs</title>
<p>Existing disease-gene prioritization methods vary based on the types of inputs that they use to produce their varied outputs. Functionality of prioritization methods is defined by previously known information about the disease and by candidate search space <xref ref-type="bibr" rid="pcbi.1002902-Tranchevent3">[124]</xref>, which may be either submitted by the user or automatically selected by the tool. Disease information is generally limited to lists of known disease-associated genes, affected tissues and pathways and relevant keywords. The candidate search space does not have to be input at all (<italic>i.e.</italic> the entire genome) or be defined by the suspect (for varied experimental reasons) genomic region. The prioritization accuracy, in large part, depends on the accuracy and specificity of the inputs. Thus, providing a list of very broad keywords may reduce the performance specificity, while incorrect candidate search space automatically decreases sensitivity. Prioritization methods generally output ranked/ordered lists of genes, oftentimes associated with p-values, classifier scores, etc.</p>
<p>Overall, input and output requirements and formats are a very important part of establishing a tool's relevance for its users. As with other bioinformatics methods, the ease use and the steepness of learning curve for a given gene prioritization method often define the user base at least as strictly as does its performance.</p>
</sec><sec id="s6">
<title>5. The Processing</title>
<p>Gene prioritization methods use different algorithms to make sense of all the data they extract, including mathematical/statistical models/methods (<italic>e.g.</italic> GeneProspector <xref ref-type="bibr" rid="pcbi.1002902-Yu2">[125]</xref>), fuzzy logic (<italic>e.g.</italic> ToppGene <xref ref-type="bibr" rid="pcbi.1002902-Chen3">[126]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Chen4">[127]</xref>), and artificial learning devices (<italic>e.g.</italic> PROSPECTR <xref ref-type="bibr" rid="pcbi.1002902-Adie1">[54]</xref>), among others. Some methods use combinations of the above. Objectively, there is no one methodology that is better than the others for all data inputs. For more details on computational methods used in the various approaches please refer to relevant tool publications and method-specific computer science/mathematics literature, <italic>e.g.</italic> <xref ref-type="bibr" rid="pcbi.1002902-Nilsson1">[128]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Bouckaert1">[129]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Frank1">[130]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Gewehr1">[131]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Steeb1">[132]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-BenGal1">[133]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Habra1">[134]</xref>.</p>
<p>To illustrate the general concepts of relying on the various computational techniques for gene prioritization we will consider the use of an artificial neural network (ANN). Keep in mind that while methods and their requirements differ, the notion of identifying patterns in the data that may be indicative disease-gene involvement remains the same throughout. In simplest terms, a neural network is essentially a mathematical model that defines a function <italic>f</italic>: <italic>X</italic>→<italic>Y</italic>, where a distribution over X (the inputs to the network) is mapped to a distribution over <italic>Y</italic> (the outputs/classifications). The word “network" in the name “artificial neural network" refers to the set of connections between the “neurons" (<xref ref-type="fig" rid="pcbi-1002902-g005">Figure 5</xref>). The functionality of the network is defined by the transmission of signal from activated neurons in one layer to the neurons in another layer via established (and weighed) connections. Besides the choice and number of inputs and outputs, the parameters defining a given ANN are (1) interconnection patterns, (2) the process by which the weights of connections are selected/updated (learning function), and (3) the activation thresholds (functions) of any one given neuron. “Training" a network means optimizing these parameters using an existing set of inputs (and, possibly, outputs). Ultimately, a trained network could then relatively accurately recognize learned patterns in previously unseen data. For more details regarding the possible types and parameters of neural networks see <xref ref-type="bibr" rid="pcbi.1002902-Steeb1">[132]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Habra1">[134]</xref>. For an illustration of network application see <xref ref-type="sec" rid="pcbi-1002902-box002">Box 2</xref> and <xref ref-type="fig" rid="pcbi-1002902-g005">Figure 5</xref>.</p>
<fig id="pcbi-1002902-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1002902.g005</object-id><label>Figure 5</label><caption>
<title>Predicting gene-disease involvement using artificial neural networks (ANNs).</title>
<p>In a supervised learning paradigm, the neural networks are trained using experimental data correlating inputs (descriptive features relating genes to diseases) to outputs (likelihood of gene-disease involvement). The training and testing procedures for the generalized network (Panel A) are described in text. In our example, the WEKA <xref ref-type="bibr" rid="pcbi.1002902-Bouckaert1">[129]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Frank1">[130]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Gewehr1">[131]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Hall1">[139]</xref> ANN (Panel B; a = 0.5, λ = 0.2) is trained using the training set (Panel C) repeated 500 times (epochs). The network “memorizes" (Predictions in Panel C) the patterns in the training set and is capable of making accurate predictions for four out of seven instances it has not seen before (test set, Panel D). It is important to note here that the erroneously assigned instances (yellow highlight) in the test set are, for the most part, unlike the training. The first one has very little literature correlation (0.01), while sequence similarity to another disease-involved gene is fairly high 0.55). The second maps an unlikely candidate gene (very low literature, no homology) to disease, and the third has barely enough literature mapping and borderline homology. Representation of neither of these instances was consistently present in the training set. This example highlights the importance of training using a representative training set, while testing on a set that is not equivalent to training.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002902.g005" position="float" xlink:type="simple"/></fig><boxed-text id="pcbi-1002902-box002" position="float"><sec id="s6a1">
<title>Box 2. Illustrating basic functionality of a standard (on-line fully-interconnected feed-forward sigmoid-function back-propagating) neural network</title>
<p>In <xref ref-type="fig" rid="pcbi-1002902-g005">Figure 5A</xref> example network there are three fully interconnected layers of neurons (input, hidden, and output layers); <italic>i.e.</italic> each neuron in one layer is connected to every neuron in the next layer. The three input neurons encode biologically relevant pieces of data relating a given gene G to a given disease D. For each G and D, <italic>i_neuron1</italic> is the fraction of articles (out of 1000) containing in-text co-occurrences of G and D and <italic>i_neuron2</italic> represents the presence/absence of a sequence-similar gene G' associated with D (<italic>i_neuron3</italic> = G/G' sequence identity). The hidden (inference) layer consists of two neurons <italic>h_neuron1</italic> and <italic>h_neuron2</italic> with activation thresholds θ<sub>1</sub> and θ<sub>2</sub>, respectively. The single output, <italic>o_neuron</italic> (threshold θ<sub>O</sub>) represents the involvement of G in causing D: 0 = no involvement, 1 = direct causation. The starting weights of the network (w<sub>i1-h1</sub>, w<sub>i1-h2</sub>…w<sub>h2-o</sub>) are arbitrarily assigned random values between 0 and 1. Intuitively, the function of the network is to convert input neuron values into output neuron values via a network of weights and hidden neurons. Mathematically, the network is described as follows:</p>
<p>The value (<italic>d<sub>x</sub></italic>) of neuron <italic>x</italic> is the sum of inputs into <italic>x</italic> from the previous layer of neurons (<italic>Y<sub>i = 1</sub></italic><sub>→<italic>n</italic></sub> in general; in our example: <italic>I<sub>1</sub></italic><sub>→<italic>3</italic></sub>, <italic>H<sub>1</sub></italic><sub>→<italic>2</italic></sub>). Each of the <italic>n</italic> inputs is a product of value of neuron <italic>Y<sub>i</sub></italic> and weight of connection between <italic>Y<sub>i</sub></italic> and <italic>x</italic> (<italic>w<sub>Yi</sub></italic><sub>→<italic>x</italic></sub>).<disp-formula id="pcbi.1002902.e001"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1002902.e001" xlink:type="simple"/></disp-formula>The value of the output (<italic>z<sub>x</sub></italic>) of a neuron <italic>x</italic> based on its <italic>d<sub>x</sub></italic> and its threshold <italic>θ<sub>x</sub></italic> is:<disp-formula id="pcbi.1002902.e002"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1002902.e002" xlink:type="simple"/></disp-formula>In our case, the function (f) is a sigmoid, where a is a real number constant (optimized for any given network, but generally initially chosen to be between 0.5 and 2).<disp-formula id="pcbi.1002902.e003"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1002902.e003" xlink:type="simple"/></disp-formula>Thus, to compute the output of every neuron in the network we need to use the formula:<disp-formula id="pcbi.1002902.e004"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1002902.e004" xlink:type="simple"/></disp-formula>Note, that to compute the output of the <italic>o_neuron</italic> (<italic>z<sub>O</sub></italic>; the prediction made by the network) we first have to compute the outputs of all <italic>h_neurons</italic> (<italic>z<sub>Hi = 1</sub></italic><sub>→<italic>n</italic></sub>).</p>
<p>In a supervised learning paradigm, experimentally established pairs of inputs and outputs are given to the network during training (<xref ref-type="fig" rid="pcbi-1002902-g005">Figure 5C</xref>). After each input, the network output (<italic>z<sub>O</sub></italic>) is compared to the observed result (<italic>R</italic>). If the network makes a classification error its weights are adjusted to reflect that error. Establishing the best way to update weights and thresholds in response to error is of the major challenges of neural networks. Many techniques use some form of the delta rule – a gradient descent-based optimization algorithm that makes changes to function variables proportionate to the negative of the approximate gradient of the function at the given point. [It's OK if you didn't understand that sentence – the basic idea is to change the weights and thresholds in the direction opposite of the direction of the error]. In our example, we use the delta rule with back-propagation. This means that to compute the error of the hidden layer, the threshold of the output layer (<italic>θ<sub>O</sub></italic>) and the weights connecting the hidden layer to the output layer (<italic>w<sub>h1</sub></italic><sub>→<italic>O</italic></sub>, <italic>w<sub>h2</sub></italic><sub>→<italic>O</italic></sub>) need to be changed first.</p>
<p>The steps are as follows:</p>
<list list-type="order"><list-item>
<p>Compute the error (<italic>e<sub>O</sub></italic>) of <italic>z<sub>O</sub></italic> as compared to result <italic>R</italic>. Note, that the difference between the expected and the observed values defines the gradient (<italic>g</italic>) at the output neuron.<disp-formula id="pcbi.1002902.e005"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1002902.e005" xlink:type="simple"/></disp-formula></p>
</list-item><list-item>
<p>Compute the change in the threshold of the output layer (Δ<italic>θ<sub>O</sub></italic>), using a variable λ, the learning rate constant - a real number, often initialized to 0.1–0.2 and optimized for each network)<disp-formula id="pcbi.1002902.e006"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1002902.e006" xlink:type="simple"/></disp-formula></p>
</list-item><list-item>
<p>Compute the change in the weights connecting the hidden layer to the output, <italic>w<sub>Hi</sub></italic><sub>→<italic>O</italic></sub>.<disp-formula id="pcbi.1002902.e007"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1002902.e007" xlink:type="simple"/></disp-formula></p>
</list-item><list-item>
<p>Compute the gradient (<italic>g<sub>i</sub></italic>) at hidden neurons<disp-formula id="pcbi.1002902.e008"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1002902.e008" xlink:type="simple"/></disp-formula>Note, from here all steps are the same as above</p>
</list-item><list-item>
<p>Compute the error at <italic>z<sub>Hi</sub></italic><disp-formula id="pcbi.1002902.e009"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1002902.e009" xlink:type="simple"/></disp-formula></p>
</list-item><list-item>
<p>Compute the change in <italic>θ<sub>Hi</sub></italic><disp-formula id="pcbi.1002902.e010"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1002902.e010" xlink:type="simple"/></disp-formula></p>
</list-item><list-item>
<p>Compute the change in <italic>w<sub>Ij</sub></italic><sub>→<italic>Hi</italic></sub><disp-formula id="pcbi.1002902.e011"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1002902.e011" xlink:type="simple"/></disp-formula></p>
</list-item></list>
<p>In on-line updating mode of our example, weights and thresholds are altered after each set of input transmissions. Once the network has “seen" the full set of input/output pairs (one epoch/iteration), training continues re-using the same set until the performance is satisfactory. Note that neural networks are sensitive to dataset imbalance. <italic>I.e.</italic> it is preferable to “balance" the training data, such that the number of instances of each class is presented a roughly equal number of times.</p>
<p>In testing, updating of the weights no longer takes place; <italic>i.e.</italic> the <italic>z<sub>O</sub></italic> for any given set of inputs is constant over time. See Exercise 8 for an experience with testing. Note, there are many variations on the type and parameters of network learning (propagation mode and direction, weight update rules, thresholds for stopping, etc.) Please consult the necessary literature for more information, <italic>e.g.</italic> <xref ref-type="bibr" rid="pcbi.1002902-Habra1">[134]</xref>.</p>
</sec></boxed-text></sec><sec id="s7">
<title>6. Summary</title>
<p>The development of high throughput technologies has augmented our abilities to identify genetic deficiencies and inconsistencies that lead to the development of diseases. However, a large portion of information in the heaps of data that these methods produce is incomprehensible to the naked eye. Moreover, inferences that could potentially be made from combining different studies and existing research results are beyond reach for anyone of human (not cyborg) descent. Gene prioritization methods (<xref ref-type="table" rid="pcbi-1002902-t001">Table 1</xref>) have been developed to make sense of this data by extracting and combining the various pieces necessary to link genes to diseases. These methods rely on experimental work such as disease gene linkage analysis and genome wide studies to establish the search space of candidate genes that may possibly be involved in generating the observed phenotype. Further, they utilize mathematical and computational models of disease to filter the original set of genes based on gene and protein sequence, structure, function, interaction, expression, and tissue and cellular localization information. Data repositories that contain the necessary information are diverse in both content and format and require deep knowledge of the stored information to be properly interpreted. Moreover, the models utilizing the various sources assign different weights to the information they extract based on perceived quality and importance of each piece of data available in the context of the entire set of descriptors – a function unlikely to be reproduced in manual data interpretation. Thus, computational gene prioritization techniques serve as interpreters of both of newly retrieved data and of information contained in previous studies. They also are the bridge that connects seemingly unrelated inferences creating an easily comprehensible outlook on an important problem of disease gene annotation.</p>
<table-wrap id="pcbi-1002902-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1002902.t001</object-id><label>Table 1</label><caption>
<title>The available data sources and gene prioritization tools.</title>
</caption><alternatives><graphic id="pcbi-1002902-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002902.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Data Type</td>
<td align="left" rowspan="1" colspan="1">Data Content</td>
<td align="left" rowspan="1" colspan="1">Possible Sources</td>
<td align="left" rowspan="1" colspan="1">Tools</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>Experiment, observation</italic></td>
<td align="left" rowspan="1" colspan="1">Linkage, association, pedigree, relevant texts and other data</td>
<td align="left" rowspan="1" colspan="1">User provided</td>
<td align="left" rowspan="1" colspan="1">CAESAR <xref ref-type="bibr" rid="pcbi.1002902-Gaulton1">[140]</xref>, CANDID <xref ref-type="bibr" rid="pcbi.1002902-Hutz1">[141]</xref>, ENDEAVOR <xref ref-type="bibr" rid="pcbi.1002902-Aerts1">[122]</xref>, G2D <xref ref-type="bibr" rid="pcbi.1002902-PerezIratxeta1">[15]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-PerezIratxeta2">[16]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-PerezIratxeta3">[17]</xref>, Gentrepid <xref ref-type="bibr" rid="pcbi.1002902-George1">[142]</xref>, GeneDistiller <xref ref-type="bibr" rid="pcbi.1002902-Seelow1">[121]</xref>, PGMapper <xref ref-type="bibr" rid="pcbi.1002902-Xiong1">[143]</xref>, PRINCE <xref ref-type="bibr" rid="pcbi.1002902-Vanunu1">[144]</xref>, Prioritizer <xref ref-type="bibr" rid="pcbi.1002902-Franke1">[145]</xref>, SUSPECTS <xref ref-type="bibr" rid="pcbi.1002902-Adie2">[146]</xref>, ToppGene <xref ref-type="bibr" rid="pcbi.1002902-Chen3">[126]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Chen4">[127]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>Sequence, structure, meta-data</italic></td>
<td align="left" rowspan="1" colspan="1">Sequence conservation, exon number, coding region length, known structural domains and sequence motifs, chromosomal location, protein localization, and other gene-centered information and predictions</td>
<td align="left" rowspan="1" colspan="1">SCOP <xref ref-type="bibr" rid="pcbi.1002902-Murzin1">[147]</xref>, PFam <xref ref-type="bibr" rid="pcbi.1002902-Finn1">[148]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Bateman1">[149]</xref>, ProSite <xref ref-type="bibr" rid="pcbi.1002902-Sigrist1">[150]</xref>, UniProt, Entrez Gene <xref ref-type="bibr" rid="pcbi.1002902-Maglott1">[151]</xref>, ENSEMBL <xref ref-type="bibr" rid="pcbi.1002902-Flicek1">[152]</xref>, InterPro <xref ref-type="bibr" rid="pcbi.1002902-Hunter1">[153]</xref>, LocDB <xref ref-type="bibr" rid="pcbi.1002902-Rastogi1">[154]</xref>, GeneCards <xref ref-type="bibr" rid="pcbi.1002902-Rebhan1">[155]</xref>, PredictProtein <xref ref-type="bibr" rid="pcbi.1002902-Rost1">[156]</xref></td>
<td align="left" rowspan="1" colspan="1">CAESAR, CANDID, ENDEAVOR, G2D, Gentrepid, GeneDistiller, GeneProspector <xref ref-type="bibr" rid="pcbi.1002902-Yu2">[125]</xref>, MedSim <xref ref-type="bibr" rid="pcbi.1002902-Schlicker2">[157]</xref>, MimMiner <xref ref-type="bibr" rid="pcbi.1002902-vanDriel1">[158]</xref>, PGMapper, PhenoPred <xref ref-type="bibr" rid="pcbi.1002902-Radivojac1">[159]</xref>, Prioritizer, PROSPECTR <xref ref-type="bibr" rid="pcbi.1002902-Adie1">[54]</xref>, SNPs3D <xref ref-type="bibr" rid="pcbi.1002902-Yue1">[106]</xref>, SUSPECTS, ToppGene</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>Pathway, protein-protein interaction, genetic linkage, expression</italic></td>
<td align="left" rowspan="1" colspan="1">Disease-gene associations, pathways and gene-gene/protein-protein interactions/interaction predictions, and gene expression data</td>
<td align="left" rowspan="1" colspan="1">KEGG <xref ref-type="bibr" rid="pcbi.1002902-Kanehisa1">[160]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Kanehisa2">[161]</xref>, STRING, Reactome <xref ref-type="bibr" rid="pcbi.1002902-DEustachio1">[162]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Matthews1">[163]</xref>, DIP <xref ref-type="bibr" rid="pcbi.1002902-Xenarios1">[164]</xref>, BioGRID <xref ref-type="bibr" rid="pcbi.1002902-Stark1">[165]</xref>, GEO <xref ref-type="bibr" rid="pcbi.1002902-Barrett1">[166]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Edgar1">[167]</xref>, ArrayExpress <xref ref-type="bibr" rid="pcbi.1002902-Parkinson1">[168]</xref>, ReLiance <xref ref-type="bibr" rid="pcbi.1002902-Iacucci1">[169]</xref></td>
<td align="left" rowspan="1" colspan="1">CAESAR, CANDID, DiseaseNet <xref ref-type="bibr" rid="pcbi.1002902-Navlakha1">[170]</xref>, ENDEAVOR, G2D, Gentrepid, GeneDistiller, GeneWanderer <xref ref-type="bibr" rid="pcbi.1002902-Kohler1">[20]</xref>, MaxLink <xref ref-type="bibr" rid="pcbi.1002902-Ostlund1">[171]</xref>, MedSim, PGMapper, PhenoPred, PRINCE, Prioritizer, SNPs3D, SUSPECTS, ToppGene</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>Non-human data</italic></td>
<td align="left" rowspan="1" colspan="1">Information about related genes and phenotypes in other species</td>
<td align="left" rowspan="1" colspan="1">OrthoDisease <xref ref-type="bibr" rid="pcbi.1002902-OBrien1">[172]</xref>, OrthoMCL <xref ref-type="bibr" rid="pcbi.1002902-Li1">[173]</xref>, MGD <xref ref-type="bibr" rid="pcbi.1002902-Bult1">[174]</xref>, Pathbase <xref ref-type="bibr" rid="pcbi.1002902-Schofield1">[175]</xref></td>
<td align="left" rowspan="1" colspan="1">CAESAR, CANDID, ENDEAVOR, GeneDistiller, GeneProspector, GeneWanderer, MedSim, Prioritizer, PROSPECTR, SNPs3D, SUSPECTS, ToppGene</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>Ontologies</italic></td>
<td align="left" rowspan="1" colspan="1">Gene, disease, phenotype, and anatomic ontologies</td>
<td align="left" rowspan="1" colspan="1">GO, DO <xref ref-type="bibr" rid="pcbi.1002902-Osborne1">[176]</xref>, MPO <xref ref-type="bibr" rid="pcbi.1002902-Smith2">[177]</xref>, <xref ref-type="bibr" rid="pcbi.1002902-Smith3">[178]</xref>, HPO <xref ref-type="bibr" rid="pcbi.1002902-Robinson1">[179]</xref>, eVOC <xref ref-type="bibr" rid="pcbi.1002902-Kelso1">[180]</xref></td>
<td align="left" rowspan="1" colspan="1">CAESAR, ENDEAVOR, G2D, GeneDistiller, MedSim, PhenoPred, Prioritizer, SNPs3D, ToppGene</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>Mutation associations and effects</italic></td>
<td align="left" rowspan="1" colspan="1">Information about existing mutations, their functional and structural effects and their association with diseases, predictions of functional or structural effects for the mutations in the gene in question</td>
<td align="left" rowspan="1" colspan="1">dbSNP, PMD <xref ref-type="bibr" rid="pcbi.1002902-Kawabata1">[111]</xref>, GAD, DMDM, SNAP, PolyDoms, SNPdbe, SNPselector, RAVEN, SNPeffect, PHD-SNP, <email xlink:type="simple">Mutation@A</email> Glance, PromoLign, SIFT, PolyPhen, PupaSNP finder, FASTSNP</td>
<td align="left" rowspan="1" colspan="1">CAESAR, CANDID, GeneProspector, GeneWanderer, PROSPECTR, SNPs3D, SUSPECTS</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>Literature</italic></td>
<td align="left" rowspan="1" colspan="1">Mixed information of all types extracted from literature references (<italic>e.g.</italic> disease-gene correlation and non-ontology based gene-function assignment)</td>
<td align="left" rowspan="1" colspan="1">PubMed, PubMed Central, HGMD <xref ref-type="bibr" rid="pcbi.1002902-Stenson1">[181]</xref>, GeneRIF, OMIM</td>
<td align="left" rowspan="1" colspan="1">CAESAR, CANDID, DiseaseNet, ENDEAVOR, G2D, Gentrepid, GeneDistiller, GeneProspector, GeneWanderer, MedSim, MimMiner, PGMapper, PolySearch <xref ref-type="bibr" rid="pcbi.1002902-Cheng1">[123]</xref>, PRINCE, Prioritizer, PROSPECTR, SNPs3D, SUSPECTS, ToppGene</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>There is a wide range of data sources that can be used to infer the above-described pieces of evidence. The existing tools try to take advantage of many (if not all) of them. This table summarizes the collections and methodologies that make current state of the art in gene prioritization possible. Note, not all resources mentioned here are utilized by all gene prioritization tools nor are all data sources available listed. Moreover, some resources may be classified as more than one data-type. Many of the resources reported here are available electronically through the gene prioritization portal <xref ref-type="bibr" rid="pcbi.1002902-Tranchevent3">[124]</xref>.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s8">
<title>7. Exercises</title>
<list list-type="order"><list-item>
<p>Search the GAD (<ext-link ext-link-type="uri" xlink:href="http://geneticassociationdb.nih.gov/" xlink:type="simple">http://geneticassociationdb.nih.gov/</ext-link>) database for all genes reported to be associated with diabetes. Refine this set to find only the positively associated genes. How many are there? Why was the total data set reduced? Count the number of unique diabetes associated genes or explain why this is not feasible. How many SNPs associate these genes with diabetes? Is it realistically possible to experimentally evaluate individual effects of each SNP in this set?</p>
</list-item><list-item>
<p>Using STRING (<ext-link ext-link-type="uri" xlink:href="http://string-db.org/" xlink:type="simple">http://string-db.org/</ext-link>), find <bold><italic>all</italic></bold> genes (hint: use limit of 50) interacting with insulin (confidence &gt;0.99). <italic>Note, this confidence limit is extremely high – computational techniques would normally deal with lower limits and thus larger data sets</italic>. What is the insulin gene name used by STRING? How many interaction partners does your query return? Switch to STRING evidence view. Pick three genes connected to insulin via text mining, but without “insulin" in their full name, and find one reference for each in PubMed (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed/</ext-link>) suggesting that these genes are involved with diabetes. Report Gene IDs (<italic>e.g.</italic> MC4R), PubMed IDs and publication citations. Use PolySearch (<ext-link ext-link-type="uri" xlink:href="http://wishart.biology.ualberta.ca/polysearch" xlink:type="simple">http://wishart.biology.ualberta.ca/polysearch</ext-link>) <bold>gene</bold> to <bold>disease</bold> mapping with your gene IDs to do the same. Does your experience confirm that the functional “molecular interaction" evidence works? Why?</p>
</list-item><list-item>
<p>In AmiGO (GO term browser, <ext-link ext-link-type="uri" xlink:href="http://www.geneontology.org" xlink:type="simple">http://www.geneontology.org</ext-link>), find the human insulin record (hint: use the insulin ID obtained above). What is the Swiss-Prot ID for insulin? Go to the term view. How many GO term associations does insulin have? Reduce the view to “molecular function" terms. How many terms are left? Create a tree view of these terms (hint: use the “Perform an action" dropdown). Which of the terms is the most exact in defining the likely molecular function of insulin (lowest term in a tree hierarchy)? Display gene products in “GO:0005158: insulin receptor binding", reduce the set to human proteins, and look at the inferred tree. How many gene products are in this term? Pick a set of three gene products (report IDs) and use them to search PolySearch for diabetes associations. In question 3 we used the “common pathway" evidence to show the relationship of genes to diabetes. What type of predictive evidence is used here?</p>
</list-item><list-item>
<p>Search the Mammalian Phenotype Ontology for keyword “diabetes" and select increased susceptibility (MPO, <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/searches/MP_form.shtml" xlink:type="simple"> </ext-link>http://www.informatics.jax.org/searches/MP_form.shtml). How many genotypes are returned? Display the genotypes and click on the Aire<sup>tm1Mand</sup>/Aire<sup>+</sup> genotype for further exploration. What is the affected gene? Click on gene title (Gene link in Nomenclature section) to display further information. What is an orthologue? What is the human orthologue of your mouse gene? Look up this gene in OMIM (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim" xlink:type="simple">http://www.ncbi.nlm.nih.gov/omim</ext-link>) for association with diabetes. Copy/paste the <italic>citation</italic> from OMIM, describing the gene relationship to diabetes in humans. Do your results confirm the “cross-species" evidence?</p>
</list-item><list-item>
<p>Search GeneCards (<ext-link ext-link-type="uri" xlink:href="http://www.genecards.org" xlink:type="simple">http://www.genecards.org</ext-link>, utilize advanced search) for genes expressing in the pancreas (hint: pancreatic tissue is often affected in diabetes). How many are there? Explore the GeneCard for CCKBR for diabetes association. Do you find that this gene confirms the “disease compartment" evidence? What database, referenced in GeneCards, contains the CCKBR-diabetes association? Now look at the GeneCard of PLEKHG4. Is there evidence for this gene being associated with diabetes (whether in the GeneCards record or otherwise)? Explain your ideas in detail, paying special attention to the “disease compartment" line of evidence.</p>
</list-item><list-item>
<p>Search UniProt (<ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org" xlink:type="simple">http://www.uniprot.org</ext-link>) for all reviewed [reviewed:yes] human [organism:“Homo sapiens [9606]"] protein entries that contain natural variants with reference to diabetes [annotation:(type:natural_variations diabetes)]. Use advanced search with specific limits (<italic>i.e.</italic> sequence annotation, natural_variations, term diabetes). How many proteins fit this description? Locate the entry for insulin (identifier from question 3) and find the total number of known coding variants of this sequence. How many are annotated as associated with any form of diabetes? (hint: read the general annotation section for correspondence of abbreviations to types of diabetes). Run SNAP (<ext-link ext-link-type="uri" xlink:href="http://www.rostlab.org/services/snap/" xlink:type="simple">http://www.rostlab.org/services/snap/</ext-link>) to predict functional effects of all variants. (hint: use comma separated batch submit). How many are predicted to be functionally non-neutral? Do SNAP predictions of functional effect correlate with annotated disease associations? Does this result confirm the “mutant implication" for nsSNPs?</p>
</list-item><list-item>
<p>Search PolySearch for all genes associated with diabetes. How many results are returned? Look at the PubMed articles that associate “hemoglobin" with diabetes (follow the link from PolySearch). How many are there? Do you find this number large enough to convince you of hemoglobin-diabetes association and why? From reading article titles/extracted sentences, can you identify a biological reason for connecting hemoglobin to diabetes? If one looks especially convincing, cite that article (hint: its OK to not find one). For the first three articles, can you identify a biological reason for connecting hemoglobin to diabetes? Go back to the list of diabetes related genes and look at TCF7L2 articles. Are the biological reasons for matching TCF7L2 to diabetes clearly defined? Cite the most convincing article. Why do you think TCF7L2 is ranked lower in association than hemoglobin? Is there significant evidence for calcium channel (CACNA1E) involvement in diabetes? Consider the PubMed citations. Do you agree with PolySearch classification of this gene-disease association? Does your experience with PolySearch confirm the “text evidence" function of gene prioritization methods?</p>
</list-item><list-item>
<p>WEKA exercises (choose one).</p>
<p>Download and install WEKA (<ext-link ext-link-type="uri" xlink:href="http://www.cs.waikato.ac.nz/~ml/weka/" xlink:type="simple"> </ext-link>http://www.cs.waikato.ac.nz/∼ml/weka/). Using a text-editor (or Microsoft Excel) create comma delimited values (CSV) files identical to the ones described in <xref ref-type="fig" rid="pcbi-1002902-g005">Figure 5C–D</xref> (<italic>i.e.</italic> copy over the training and testing files and replace spaces with commas). Save the files and open the training file in WEKA's Explorer GUI. Open the training file in WEKA's Explorer GUI. You should have four columns of data (Text, Homology, ID, Disease) corresponding to four attributes of each data instance.</p>
    <list list-type="order"><list-item>
        <p>Defined Questions: Run the MultiLayer Perceptron with parameters (momentum = 0.5, learning = 0.2, trained using the training set, <xref ref-type="fig" rid="pcbi-1002902-g005">Figure 5C</xref>, repeated 500 times/epochs). Test with the test set (<xref ref-type="fig" rid="pcbi-1002902-g005">Figure 5D</xref>) and output predictions for each test entry (make a screenshot). Assuming that everything predicted below 0 is 0, and everything above is 1. What is your performance (number of true/false positives/negatives, positive/negative accuracy/coverage, overall accuracy)? Try using the Decision Stump classifier with default parameters (take screenshot of output). If everything below 0.5 is 0, and everything above is 1, what is your performance? Is it better or worse than the neural net?</p>
    </list-item><list-item>
        <p>Open ended: Experiment with different tools available from WEKA's Classify section setting the testing set to your test-file's location. First, run the MultiLayer Perceptron with parameters as described in <xref ref-type="fig" rid="pcbi-1002902-g005">Figure 5</xref>, then try to alter the parameters (momentum term, learning rate, and number of epochs). Try using Linear Regression, Decision Table, or Decision Stump classifiers with default parameters. Is your performance on the test set better or worse? Close the WEKA Explorer, reformat your train/test files in the text editor to replace Disease column values by Booleans (True/False) values, and re-open the training file. Use BayesianNet and RandomForest classifiers to test on the testing file. Does you performance improve? Note, that without further understanding of each of the tools, it is nearly impossible to determine which method is applicable to your data.</p>
</list-item></list>
</list-item>
</list>
<p>Answers to the Exercises can be found in <xref ref-type="supplementary-material" rid="pcbi.1002902.s001">Text S1</xref>.</p>
<boxed-text id="pcbi-1002902-box004" position="float"><sec id="s8a1">
<title>Further Reading</title>
<list list-type="bullet"><list-item>
<p>Alterovitz G, Ramoni M, eds. (2010) Knowledge-based bioinformatics: from analysis to interpretation. Padstow, Cornwall: John Wiley and Sons Ltd.</p>
</list-item><list-item>
<p>Bromberg Y, Capriotti E, eds. (2012) SNP-SIG 2011: identification and annotation of SNPs in the context of structure, function and disease. Proceedings from SNP-SIG 2011 conference, Vienna, Austria. BMC Genomics 13 Supp 4.</p>
</list-item><list-item>
<p>Chen JY, Youn E, Mooney SD (2009) Connecting protein interaction data, mutations, and disease using bioinformatics. Methods Mol Biol 541: 449–461.</p>
</list-item><list-item>
<p>Dalkilic MM, Costello JC, Clark WT, Radivojac P (2008) From protein-disease associations to disease informatics. Front Biosci 13: 3391–3407.</p>
</list-item><list-item>
<p>Evans JA, Rzhetsky A (2011) Advancing science through mining libraries, ontologies, and communities. J Biol Chem 286: 23659–23666.</p>
</list-item><list-item>
<p>Kann MG (2007) Protein interactions and disease: computational approaches to uncover the etiology of diseases. Brief Bioinform 8: 333–346.</p>
</list-item><list-item>
<p>Krallinger M, Leitner F, Valencia A (2010) Analysis of biological processes and diseases using text mining approaches. Methods Mol Biol 593: 341–382.</p>
</list-item><list-item>
<p>Liberles DA, Teichmann SA, Bahar I, Bastolla U, Bloom J, et al. (2012) The interface of protein structure, protein biophysics, and molecular evolution. Protein Sci 21: 769–785.</p>
</list-item><list-item>
<p>Maulik U, Bandyopadhyay S, Wang JTL, eds. (2010) Computational intelligence and pattern analysis in biological informatics. Hoboken, NJ: John Wiley and Sons, Inc.</p>
</list-item><list-item>
<p>Mooney SD, Krishnan VG, Evani US (2010) Bioinformatic tools for identifying disease gene and SNP candidates. Methods Mol Biol 628: 307–319.</p>
</list-item><list-item>
<p>Moreau Y, Tranchevent LC (2012) Computational tools for prioritizing candidate genes: boosting disease gene discovery. Nat Rev Genet 13: 523–536.</p>
</list-item><list-item>
<p>Oti M, Brunner HG (2007) The modular nature of genetic diseases. Clin Genet 71: 1–11.</p>
</list-item><list-item>
<p>Piro RM, Di Cunto F (2007) Computational approaches to disease-gene prediction: rationale, classification and successes. FEBS J 279: 678–696.</p>
</list-item></list>
</sec></boxed-text><boxed-text id="pcbi-1002902-box005" position="float"><sec id="s8c1">
<title>Glossary</title>
<list list-type="bullet"><list-item>
<p><bold>Annotation</bold> – any additional information about a genetic sequence. Annotation types are extremely varied, including functional, structural, regulatory, location-related, organism-specific, experimentally derived, predicted, etc.</p>
</list-item><list-item>
<p><bold>CNV</bold>, copy number variation – an alteration of the genome, which results in an individual having a non-standard number of copies of one or more DNA sections.</p>
</list-item><list-item>
<p><bold>Gene prioritization</bold> – the process of arranging possible disease causing genes in order of their likelihood in disease involvement.</p>
</list-item><list-item>
<p><bold>GWAS</bold>, genome wide association studies – the examination of all genes in the genome to correlate their variation to phenotypic trait variation across individuals in a given population.</p>
</list-item><list-item>
<p><bold>Genetic linkage</bold> – tendency of certain genetic regions on the same chromosome to be inherited together more often than expected due to limited recombination between them.</p>
</list-item><list-item>
<p><bold>Genetic marker</bold> – a DNA sequence variant with a known location that can be used to identify specific subsets of individuals (cells, species, individual organisms, etc.).</p>
</list-item><list-item>
<p><bold>Homologue</bold> – a gene derived from a common ancestor with the reference gene. Generally, gene A is a homologue of gene B if both are derived from a common ancestor.</p>
</list-item><list-item>
<p><bold>Linkage disequilibrium</bold> – tendency of certain genetic regions (not necessarily on the same chromosome) to be inherited together more often that expected from considering their population frequencies. In reference to gene prioritization, this phenomenon may complicate establishment of causal genes due to their consistent inheritance in complex with non-causal genetic regions.</p>
</list-item><list-item>
<p><bold>Orthologues</bold> – homologous genes separated by a speciation event. Generally, gene A is an orthologue of gene B if A and B are homologous, but reside in different species. Orthologues often perform the same general function in different organisms.</p>
</list-item><list-item>
<p><bold>Paralogues</bold> – homologous genes separated by a duplication event (often followed by copy differentiation). Generally, gene A is a paralogue of gene B if A and B are homologous and reside in the same species. A and B can be functionally identical or, on contraire, very different, but are often only slightly dissimilar.</p>
</list-item><list-item>
<p><bold>Pleiotropy</bold> – the influence of a single gene on a number of phenotypic traits.</p>
</list-item></list>
</sec></boxed-text></sec><sec id="s9">
<title>Supporting Information</title>
<supplementary-material id="pcbi.1002902.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pcbi.1002902.s001" position="float" xlink:type="simple"><label>Text S1</label><caption>
<p>Answers to Exercises.</p>
<p>(DOCX)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>The author would like to thank Chengsheng Zhu (Rutgers University), Chani Weinreb (Columbia University) and Nikolay Samusik (Max Planck Institute, Dresden) for critical reading and comments to the manuscript. She also acknowledges the help of Gregory Behringer (Rutgers University) and of all of the students of the Spring 2012 Bioinformatics course at Rutgers in testing the exercises.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pcbi.1002902-Herrick1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Herrick</surname><given-names>JB</given-names></name> (<year>2001</year>) <article-title>Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910</article-title>. <source>Yale J Biol Med</source> <volume>74</volume>: <fpage>179</fpage>–<lpage>184</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Pauling1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pauling</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Itano</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Singer</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Wells</surname><given-names>IC</given-names></name> (<year>1949</year>) <article-title>Sickle cell anemia, a molecular disease</article-title>. <source>Science</source> <volume>109</volume>: <fpage>443</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Ingram1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ingram</surname><given-names>VM</given-names></name> (<year>1956</year>) <article-title>A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin</article-title>. <source>Nature</source> <volume>178</volume>: <fpage>792</fpage>–<lpage>794</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Gusella1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gusella</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Wexler</surname><given-names>NS</given-names></name>, <name name-style="western"><surname>Conneally</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Naylor</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>MA</given-names></name>, <etal>et al</etal>. (<year>1983</year>) <article-title>A polymorphic DNA marker genetically linked to Huntington's disease</article-title>. <source>Nature</source> <volume>306</volume>: <fpage>234</fpage>–<lpage>238</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Woo1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Woo</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Lidsky</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Guttler</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Chandra</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Robson</surname><given-names>KJ</given-names></name> (<year>1983</year>) <article-title>Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria</article-title>. <source>Nature</source> <volume>306</volume>: <fpage>151</fpage>–<lpage>155</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Robertson1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Robertson</surname><given-names>M</given-names></name> (<year>1984</year>) <article-title>Towards a medical eugenics?</article-title> <source>Br Med J (Clin Res Ed)</source> <volume>288</volume>: <fpage>429</fpage>–<lpage>430</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><article-title>A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group</article-title>. <source>Cell</source> <volume>72</volume>: <fpage>971</fpage>–<lpage>983</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Yip1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yip</surname><given-names>YL</given-names></name>, <name name-style="western"><surname>Famiglietti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gos</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Duek</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>David</surname><given-names>FP</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Annotating single amino acid polymorphisms in the UniProt/Swiss-Prot knowledgebase</article-title>. <source>Hum Mutat</source> <volume>29</volume>: <fpage>361</fpage>–<lpage>366</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-UniProt1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><collab xlink:type="simple">UniProt Consortium</collab> (<year>2010</year>) <article-title>The Universal Protein Resource (UniProt) in 2010</article-title>. <source>Nucleic Acids Res</source> <volume>38</volume>: <fpage>D142</fpage>–<lpage>148</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Bairoch1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bairoch</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Apweiler</surname><given-names>R</given-names></name> (<year>2000</year>) <article-title>The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000</article-title>. <source>Nucleic Acids Res</source> <volume>28</volume>: <fpage>45</fpage>–<lpage>48</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Moreau1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moreau</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tranchevent</surname><given-names>LC</given-names></name> (<year>2012</year>) <article-title>Computational tools for prioritizing candidate genes: boosting disease gene discovery</article-title>. <source>Nature reviews Genetics</source> <volume>13</volume>: <fpage>523</fpage>–<lpage>536</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Potter1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Potter</surname><given-names>JD</given-names></name> (<year>1999</year>) <article-title>Colorectal cancer: molecules and populations</article-title>. <source>J Natl Cancer Inst</source> <volume>91</volume>: <fpage>916</fpage>–<lpage>932</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Frosst1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Frosst</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Blom</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Milos</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Goyette</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sheppard</surname><given-names>CA</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase</article-title>. <source>Nat Genet</source> <volume>10</volume>: <fpage>111</fpage>–<lpage>113</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Thomas1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thomas</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Conti</surname><given-names>DV</given-names></name>, <name name-style="western"><surname>Baurley</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nijhout</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Reed</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Use of pathway information in molecular epidemiology</article-title>. <source>Hum Genomics</source> <volume>4</volume>: <fpage>21</fpage>–<lpage>42</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-PerezIratxeta1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Perez-Iratxeta</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bork</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Andrade</surname><given-names>MA</given-names></name> (<year>2002</year>) <article-title>Association of genes to genetically inherited diseases using data mining</article-title>. <source>Nat Genet</source> <volume>31</volume>: <fpage>316</fpage>–<lpage>319</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-PerezIratxeta2"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Perez-Iratxeta</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bork</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Andrade-Navarro</surname><given-names>MA</given-names></name> (<year>2007</year>) <article-title>Update of the G2D tool for prioritization of gene candidates to inherited diseases</article-title>. <source>Nucleic Acids Res</source> <volume>35</volume>: <fpage>W212</fpage>–<lpage>216</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-PerezIratxeta3"><label>17</label>
<mixed-citation publication-type="other" xlink:type="simple">Perez-Iratxeta C, Bork P, Andrade MA (2010) G2D: Candidate Genes to Inherited Diseases.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Tranchevent1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tranchevent</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Barriot</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Van Vooren</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Van Loo</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>ENDEAVOUR update: a web resource for gene prioritization in multiple species</article-title>. <source>Nucleic Acids Res</source> <volume>36</volume>: <fpage>W377</fpage>–<lpage>384</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Tranchevent2"><label>19</label>
<mixed-citation publication-type="book" xlink:type="simple">Tranchevent LC, Moreau Y (2009) ENDEAVOUR.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Kohler1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kohler</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bauer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Horn</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>PN</given-names></name> (<year>2008</year>) <article-title>Walking the interactome for prioritization of candidate disease genes</article-title>. <source>Am J Hum Genet</source> <volume>82</volume>: <fpage>949</fpage>–<lpage>958</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Kohler2"><label>21</label>
<mixed-citation publication-type="book" xlink:type="simple">Kohler S (2008) GeneWanderer.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Sun1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name> (<year>2010</year>) <article-title>A comparative study of cancer proteins in the human protein-protein interaction network</article-title>. <source>BMC Genomics</source> <volume>11 Suppl 3</volume>: <fpage>S5</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Gandhi1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gandhi</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mathivanan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Karthick</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chandrika</surname><given-names>KN</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets</article-title>. <source>Nat Genet</source> <volume>38</volume>: <fpage>285</fpage>–<lpage>293</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Jensen1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jensen</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Kuhn</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stark</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chaffron</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Creevey</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>STRING 8–a global view on proteins and their functional interactions in 630 organisms</article-title>. <source>Nucleic Acids Res</source> <volume>37</volume>: <fpage>D412</fpage>–<lpage>416</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Snel1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Snel</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lehmann</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Bork</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Huynen</surname><given-names>MA</given-names></name> (<year>2000</year>) <article-title>STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene</article-title>. <source>Nucleic Acids Res</source> <volume>28</volume>: <fpage>3442</fpage>–<lpage>3444</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Huszar1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huszar</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Fairchild-Huntress</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Dunmore</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>Q</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Targeted disruption of the melanocortin-4 receptor results in obesity in mice</article-title>. <source>Cell</source> <volume>88</volume>: <fpage>131</fpage>–<lpage>141</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-LubranoBerthelier1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lubrano-Berthelier</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Le Stunff</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bougneres</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Vaisse</surname><given-names>C</given-names></name> (<year>2004</year>) <article-title>A homozygous null mutation delineates the role of the melanocortin-4 receptor in humans</article-title>. <source>J Clin Endocrinol Metab</source> <volume>89</volume>: <fpage>2028</fpage>–<lpage>2032</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Farooqi1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Farooqi</surname><given-names>IS</given-names></name>, <name name-style="western"><surname>Keogh</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Yeo</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Lank</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Cheetham</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene</article-title>. <source>N Engl J Med</source> <volume>348</volume>: <fpage>1085</fpage>–<lpage>1095</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Challis1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Challis</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Coll</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Yeo</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Pinnock</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Dickson</surname><given-names>SL</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36)</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>101</volume>: <fpage>4695</fpage>–<lpage>4700</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Yaswen1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yaswen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Diehl</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Brennan</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Hochgeschwender</surname><given-names>U</given-names></name> (<year>1999</year>) <article-title>Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin</article-title>. <source>Nat Med</source> <volume>5</volume>: <fpage>1066</fpage>–<lpage>1070</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Helder1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Helder</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Collier</surname><given-names>DA</given-names></name> (<year>2011</year>) <article-title>The genetics of eating disorders</article-title>. <source>Curr Top Behav Neurosci</source> <volume>6</volume>: <fpage>157</fpage>–<lpage>175</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-vanNoort1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Noort</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Snel</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Huynen</surname><given-names>MA</given-names></name> (<year>2003</year>) <article-title>Predicting gene function by conserved co-expression</article-title>. <source>Trends Genet</source> <volume>19</volume>: <fpage>238</fpage>–<lpage>242</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Huang1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Gunter</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Arend</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Arias-Pulido</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma</article-title>. <source>Am J Obstet Gynecol</source> <volume>203</volume>: <fpage>e241</fpage>–<lpage>245</lpage>, <page-range>242, e241-245</page-range>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Jesmin1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jesmin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rashid</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Jamil</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hontecillas</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bassaganya-Riera</surname><given-names>J</given-names></name> (<year>2010</year>) <article-title>Gene regulatory network reveals oxidative stress as the underlying molecular mechanism of type 2 diabetes and hypertension</article-title>. <source>BMC Med Genomics</source> <volume>3</volume>: <fpage>45</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Smith1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith</surname><given-names>HO</given-names></name>, <name name-style="western"><surname>Leslie</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Qualls</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Revankar</surname><given-names>CM</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>GPR30: a novel indicator of poor survival for endometrial carcinoma</article-title>. <source>Am J Obstet Gynecol</source> <volume>196</volume>: <fpage>e381</fpage>–<lpage>389</lpage>, <page-range>386, e381-389</page-range> discussion 386 e389–311.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Elizondo1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Elizondo</surname><given-names>LI</given-names></name>, <name name-style="western"><surname>Jafar-Nejad</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Clewing</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Boerkoel</surname><given-names>CF</given-names></name> (<year>2009</year>) <article-title>Gene clusters, molecular evolution and disease: a speculation</article-title>. <source>Curr Genomics</source> <volume>10</volume>: <fpage>64</fpage>–<lpage>75</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Spellman1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spellman</surname><given-names>PT</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>GM</given-names></name> (<year>2002</year>) <article-title>Evidence for large domains of similarly expressed genes in the Drosophila genome</article-title>. <source>J Biol</source> <volume>1</volume>: <fpage>5</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Yu1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Louie</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Summers</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kale</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Gopishetty</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Two distinct pathways for metabolism of theophylline and caffeine are coexpressed in Pseudomonas putida CBB5</article-title>. <source>J Bacteriol</source> <volume>191</volume>: <fpage>4624</fpage>–<lpage>4632</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Singer1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Singer</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Lloyd</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Huminiecki</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Wolfe</surname><given-names>KH</given-names></name> (<year>2005</year>) <article-title>Clusters of co-expressed genes in mammalian genomes are conserved by natural selection</article-title>. <source>Mol Biol Evol</source> <volume>22</volume>: <fpage>767</fpage>–<lpage>775</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Hurst1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hurst</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Pal</surname><given-names>C</given-names></name> (<year>2002</year>) <article-title>Natural selection promotes the conservation of linkage of co-expressed genes</article-title>. <source>Trends Genet</source> <volume>18</volume>: <fpage>604</fpage>–<lpage>606</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Dawkins1"><label>41</label>
<mixed-citation publication-type="book" xlink:type="simple">Dawkins R (1976) The Selfish Gene. New York City: Oxford University Press.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Gu1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Steinmetz</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Scharfe</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>RW</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Role of duplicate genes in genetic robustness against null mutations</article-title>. <source>Nature</source> <volume>421</volume>: <fpage>63</fpage>–<lpage>66</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Conant1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Conant</surname><given-names>GC</given-names></name>, <name name-style="western"><surname>Wagner</surname><given-names>A</given-names></name> (<year>2004</year>) <article-title>Duplicate genes and robustness to transient gene knock-downs in Caenorhabditis elegans</article-title>. <source>Proc Biol Sci</source> <volume>271</volume>: <fpage>89</fpage>–<lpage>96</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Hsiao1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsiao</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Vitkup</surname><given-names>D</given-names></name> (<year>2008</year>) <article-title>Role of duplicate genes in robustness against deleterious human mutations</article-title>. <source>PLoS Genet</source> <volume>4</volume>: <fpage>e1000014</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1000014" xlink:type="simple">10.1371/journal.pgen.1000014</ext-link></comment>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Ashburner1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ashburner</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ball</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Blake</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Botstein</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Butler</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Gene ontology: tool for the unification of biology. The Gene Ontology Consortium</article-title>. <source>Nat Genet</source> <volume>25</volume>: <fpage>25</fpage>–<lpage>29</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Mencarelli1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mencarelli</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Maestrini</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Alberti</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Verti</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Sporadic mutations in melanocortin receptor 3 in morbid obese individuals</article-title>. <source>Eur J Hum Genet</source> <volume>16</volume>: <fpage>581</fpage>–<lpage>586</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Lord1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lord</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Stevens</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Brass</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Goble</surname><given-names>CA</given-names></name> (<year>2003</year>) <article-title>Investigating semantic similarity measures across the Gene Ontology: the relationship between sequence and annotation</article-title>. <source>Bioinformatics</source> <volume>19</volume>: <fpage>1275</fpage>–<lpage>1283</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Wang1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>JZ</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Payattakool</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>CF</given-names></name> (<year>2007</year>) <article-title>A new method to measure the semantic similarity of GO terms</article-title>. <source>Bioinformatics</source> <volume>23</volume>: <fpage>1274</fpage>–<lpage>1281</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-delPozo1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>del Pozo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pazos</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Valencia</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title>Defining functional distances over gene ontology</article-title>. <source>BMC Bioinformatics</source> <volume>9</volume>: <fpage>50</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Schlicker1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schlicker</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Albrecht</surname><given-names>M</given-names></name> (<year>2010</year>) <article-title>FunSimMat update: new features for exploring functional similarity</article-title>. <source>Nucleic Acids Res</source> <volume>38</volume>: <fpage>D244</fpage>–<lpage>D248</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Punta1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Punta</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ofran</surname><given-names>Y</given-names></name> (<year>2008</year>) <article-title>The rough guide to in silico function prediction, or how to use sequence and structure information to predict protein function</article-title>. <source>PLoS Comput Biol</source> <volume>4</volume>: <fpage>e1000160</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pcbi.1000160" xlink:type="simple">10.1371/journal.pcbi.1000160</ext-link></comment>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Rentzsch1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rentzsch</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Orengo</surname><given-names>CA</given-names></name> (<year>2009</year>) <article-title>Protein function prediction–the power of multiplicity</article-title>. <source>Trends Biotechnol</source> <volume>27</volume>: <fpage>210</fpage>–<lpage>219</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-LopezBigas1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lopez-Bigas</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ouzounis</surname><given-names>CA</given-names></name> (<year>2004</year>) <article-title>Genome-wide identification of genes likely to be involved in human genetic disease</article-title>. <source>Nucleic Acids Res</source> <volume>32</volume>: <fpage>3108</fpage>–<lpage>3114</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Adie1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adie</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Porteous</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Pickard</surname><given-names>BS</given-names></name> (<year>2005</year>) <article-title>Speeding disease gene discovery by sequence based candidate prioritization</article-title>. <source>BMC Bioinformatics</source> <volume>6</volume>: <fpage>55</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Iakoucheva1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iakoucheva</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Lawson</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Obradovic</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Dunker</surname><given-names>AK</given-names></name> (<year>2002</year>) <article-title>Intrinsic disorder in cell-signaling and cancer-associated proteins</article-title>. <source>J Mol Biol</source> <volume>323</volume>: <fpage>573</fpage>–<lpage>584</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Staubert1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Staubert</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tarnow</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Brumm</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Pitra</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gudermann</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Evolutionary aspects in evaluating mutations in the melanocortin 4 receptor</article-title>. <source>Endocrinology</source> <volume>148</volume>: <fpage>4642</fpage>–<lpage>4648</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Xiang1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xiang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Litherland</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Sorensen</surname><given-names>NB</given-names></name>, <name name-style="western"><surname>Proneth</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>MS</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist</article-title>. <source>Biochemistry</source> <volume>45</volume>: <fpage>7277</fpage>–<lpage>7288</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Hinney1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hinney</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hohmann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Geller</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hess</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity</article-title>. <source>J Clin Endocrinol Metab</source> <volume>88</volume>: <fpage>4258</fpage>–<lpage>4267</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Washington1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Washington</surname><given-names>NL</given-names></name>, <name name-style="western"><surname>Haendel</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Mungall</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Ashburner</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Westerfield</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Linking human diseases to animal models using ontology-based phenotype annotation</article-title>. <source>PLoS Biol</source> <volume>7</volume>: <fpage>e1000247</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pbio.1000247" xlink:type="simple">10.1371/journal.pbio.1000247</ext-link></comment>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Mootha1"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mootha</surname><given-names>VK</given-names></name>, <name name-style="western"><surname>Lepage</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bunkenborg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Reich</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>100</volume>: <fpage>605</fpage>–<lpage>610</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Ala1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ala</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Piro</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Grassi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Damasco</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Silengo</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Prediction of human disease genes by human-mouse conserved coexpression analysis</article-title>. <source>PLoS Comput Biol</source> <volume>4</volume>: <fpage>e1000043</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pcbi.1000043" xlink:type="simple">10.1371/journal.pcbi.1000043</ext-link></comment>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Michalak1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Michalak</surname><given-names>P</given-names></name> (<year>2008</year>) <article-title>Coexpression, coregulation, and cofunctionality of neighboring genes in eukaryotic genomes</article-title>. <source>Genomics</source> <volume>91</volume>: <fpage>243</fpage>–<lpage>248</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Fukuoka1"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fukuoka</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Inaoka</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kohane</surname><given-names>IS</given-names></name> (<year>2004</year>) <article-title>Inter-species differences of co-expression of neighboring genes in eukaryotic genomes</article-title>. <source>BMC Genomics</source> <volume>5</volume>: <fpage>4</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-McKusickNathans1"><label>64</label>
<mixed-citation publication-type="book" xlink:type="simple">McKusick-Nathans Institute of Genetic Medicine (JHUB, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD) (2010) Online Mendelian Inheritance in Man, OMIM (TM).</mixed-citation>
</ref>
<ref id="pcbi.1002902-Stranger1"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stranger</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Nica</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Forrest</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Dimas</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bird</surname><given-names>CP</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Population genomics of human gene expression</article-title>. <source>Nat Genet</source> <volume>39</volume>: <fpage>1217</fpage>–<lpage>1224</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Jiang1"><label>66</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jiang</surname><given-names>B-B</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J-G</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>J-F</given-names></name> (<year>2009</year>) <article-title>Gene Prioritization for Type 2 Diabetes in Tissue-specific Protein Interaction Networks</article-title>. <source>Systems Biology</source> <volume>10801131</volume>: <fpage>319</fpage>–<lpage>328</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Koch1"><label>67</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Koch</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Steinmeyer</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Lorenz</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ricker</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>1992</year>) <article-title>The skeletal muscle chloride channel in dominant and recessive human myotonia</article-title>. <source>Science</source> <volume>257</volume>: <fpage>797</fpage>–<lpage>800</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Greer1"><label>68</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Greer</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Riddell</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Gillan</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Girouard</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Sparrow</surname><given-names>SM</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>The Nova Scotia (type D) form of Niemann-Pick disease is caused by a G3097→T transversion in NPC1</article-title>. <source>American journal of human genetics</source> <volume>63</volume>: <fpage>52</fpage>–<lpage>54</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Liou1"><label>69</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liou</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Kazimierczuk</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Hegde</surname><given-names>RS</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Analyses of variant acid beta-glucosidases: effects of Gaucher disease mutations</article-title>. <source>The Journal of biological chemistry</source> <volume>281</volume>: <fpage>4242</fpage>–<lpage>4253</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Shieh1"><label>70</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shieh</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>LY</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>CY</given-names></name> (<year>1994</year>) <article-title>Point mutation in Pompe disease in Chinese</article-title>. <source>Journal of inherited metabolic disease</source> <volume>17</volume>: <fpage>145</fpage>–<lpage>148</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Lau1"><label>71</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lau</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Neufeld</surname><given-names>EF</given-names></name> (<year>1989</year>) <article-title>A frameshift mutation in a patient with Tay-Sachs disease causes premature termination and defective intracellular transport of the alpha-subunit of beta-hexosaminidase</article-title>. <source>J Biol Chem</source> <volume>264</volume>: <fpage>21376</fpage>–<lpage>21380</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Iafrate1"><label>72</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iafrate</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Feuk</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Rivera</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Listewnik</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Donahoe</surname><given-names>PK</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Detection of large-scale variation in the human genome</article-title>. <source>Nat Genet</source> <volume>36</volume>: <fpage>949</fpage>–<lpage>951</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Chen1"><label>73</label>
<mixed-citation publication-type="other" xlink:type="simple">Chen H (2007) Cri du chat syndrome. Medscape Reference. Available: <ext-link ext-link-type="uri" xlink:href="http://emedicine.medscape.com/article/942897-overview" xlink:type="simple">http://emedicine.medscape.com/article/942897-overview</ext-link>. Accessed 16 January 2013.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Mefford1"><label>74</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mefford</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Muhle</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ostertag</surname><given-names>P</given-names></name>, <name name-style="western"><surname>von Spiczak</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Buysse</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies</article-title>. <source>PLoS Genet</source> <volume>6</volume>: <fpage>e1000962</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1000962" xlink:type="simple">10.1371/journal.pgen.1000962</ext-link></comment>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Kalscheuer1"><label>75</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kalscheuer</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>FitzPatrick</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tommerup</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bugge</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Niebuhr</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Mutations in autism susceptibility candidate 2 (AUTS2) in patients with mental retardation</article-title>. <source>Hum Genet</source> <volume>121</volume>: <fpage>501</fpage>–<lpage>509</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Alarcon1"><label>76</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alarcon</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Abrahams</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Stone</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Duvall</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Perederiy</surname><given-names>JV</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene</article-title>. <source>Am J Hum Genet</source> <volume>82</volume>: <fpage>150</fpage>–<lpage>159</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Wittig1"><label>77</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wittig</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Helbig</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Schreiber</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Franke</surname><given-names>A</given-names></name> (<year>2010</year>) <article-title>CNVineta: a data mining tool for large case-control copy number variation datasets</article-title>. <source>Bioinformatics</source> <volume>26</volume>: <fpage>2208</fpage>–<lpage>2209</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Sindi1"><label>78</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sindi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Helman</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bashir</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Raphael</surname><given-names>BJ</given-names></name> (<year>2009</year>) <article-title>A geometric approach for classification and comparison of structural variants</article-title>. <source>Bioinformatics</source> <volume>25</volume>: <fpage>i222</fpage>–<lpage>230</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Ritz1"><label>79</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ritz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bashir</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Raphael</surname><given-names>BJ</given-names></name> (<year>2010</year>) <article-title>Structural variation analysis with strobe reads</article-title>. <source>Bioinformatics</source> <volume>26</volume>: <fpage>1291</fpage>–<lpage>1298</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Botstein1"><label>80</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Botstein</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Risch</surname><given-names>N</given-names></name> (<year>2003</year>) <article-title>Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease</article-title>. <source>Nat Genet</source> <volume>33 Suppl</volume>: <fpage>228</fpage>–<lpage>237</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Chakravarti1"><label>81</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chakravarti</surname><given-names>A</given-names></name> (<year>2001</year>) <article-title>To a future of genetic medicine</article-title>. <source>Nature</source> <volume>409</volume>: <fpage>822</fpage>–<lpage>823</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Sherry1"><label>82</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sherry</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sirotkin</surname><given-names>K</given-names></name> (<year>1999</year>) <article-title>dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation</article-title>. <source>Genome Res</source> <volume>9</volume>: <fpage>677</fpage>–<lpage>679</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Rosenfeld1"><label>83</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rosenfeld</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Malhotra</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Lencz</surname><given-names>T</given-names></name> (<year>2010</year>) <article-title>Novel multi-nucleotide polymorphisms in the human genome characterized by whole genome and exome sequencing</article-title>. <source>Nucleic Acids Res</source> <volume>38</volume>: <fpage>6102</fpage>–<lpage>6111</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Zhao1"><label>84</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhao</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>LW</given-names></name>, <name name-style="western"><surname>McLeod</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Stormo</surname><given-names>GD</given-names></name> (<year>2004</year>) <article-title>PromoLign: a database for upstream region analysis and SNPs</article-title>. <source>Hum Mutat</source> <volume>23</volume>: <fpage>534</fpage>–<lpage>539</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Conde1"><label>85</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Conde</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Vaquerizas</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Santoyo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Al-Shahrour</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ruiz-Llorente</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level</article-title>. <source>Nucleic Acids Res</source> <volume>32</volume>: <fpage>W242</fpage>–<lpage>248</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Andersen1"><label>86</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Andersen</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Engstrom</surname><given-names>PG</given-names></name>, <name name-style="western"><surname>Lithwick</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Arenillas</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Eriksson</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>In silico detection of sequence variations modifying transcriptional regulation</article-title>. <source>PLoS Comput Biol</source> <volume>4</volume>: <fpage>e5</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pcbi.0040005" xlink:type="simple">10.1371/journal.pcbi.0040005</ext-link></comment>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Riva1"><label>87</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Riva</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kohane</surname><given-names>IS</given-names></name> (<year>2002</year>) <article-title>SNPper: retrieval and analysis of human SNPs</article-title>. <source>Bioinformatics</source> <volume>18</volume>: <fpage>1681</fpage>–<lpage>1685</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Xu1"><label>88</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gregory</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Hauser</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Stenger</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Pericak-Vance</surname><given-names>MA</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>SNPselector: a web tool for selecting SNPs for genetic association studies</article-title>. <source>Bioinformatics</source> <volume>21</volume>: <fpage>4181</fpage>–<lpage>4186</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Yuan1"><label>89</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yuan</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Chiou</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Tseng</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CK</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization</article-title>. <source>Nucleic Acids Res</source> <volume>34</volume>: <fpage>W635</fpage>–<lpage>641</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Chen2"><label>90</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Davydov</surname><given-names>EV</given-names></name>, <name name-style="western"><surname>Sirota</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Butte</surname><given-names>AJ</given-names></name> (<year>2010</year>) <article-title>Non-synonymous and synonymous coding SNPs show similar likelihood and effect size of human disease association</article-title>. <source>PLoS ONE</source> <volume>5</volume>: <fpage>e13574</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0013574" xlink:type="simple">10.1371/journal.pone.0013574</ext-link></comment>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Parmley1"><label>91</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Parmley</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Hurst</surname><given-names>LD</given-names></name> (<year>2007</year>) <article-title>How do synonymous mutations affect fitness?</article-title> <source>Bioessays</source> <volume>29</volume>: <fpage>515</fpage>–<lpage>519</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Ng1"><label>92</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ng</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Henikoff</surname><given-names>S</given-names></name> (<year>2006</year>) <article-title>Predicting the effects of amino acid substitutions on protein function</article-title>. <source>Annu Rev Genomics Hum Genet</source> <volume>7</volume>: <fpage>61</fpage>–<lpage>80</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Amberger1"><label>93</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Amberger</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bocchini</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Hamosh</surname><given-names>A</given-names></name> (<year>2009</year>) <article-title>McKusick's Online Mendelian Inheritance in Man (OMIM)</article-title>. <source>Nucleic Acids Res</source> <volume>37</volume>: <fpage>D793</fpage>–<lpage>796</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Schaefer1"><label>94</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schaefer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Meier</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rost</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bromberg</surname><given-names>Y</given-names></name> (<year>2012</year>) <article-title>SNPdbe: constructing an nsSNP functional impacts database</article-title>. <source>Bioinformatics</source> <volume>28</volume>: <fpage>601</fpage>–<lpage>602</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Reumers1"><label>95</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reumers</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schymkowitz</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ferkinghoff-Borg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Stricher</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Serrano</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>SNPeffect: a database mapping molecular phenotypic effects of human non-synonymous coding SNPs</article-title>. <source>Nucleic Acids Res</source> <volume>33</volume>: <fpage>D527</fpage>–<lpage>532</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Jegga1"><label>96</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jegga</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Gowrisankar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Aronow</surname><given-names>BJ</given-names></name> (<year>2007</year>) <article-title>PolyDoms: a whole genome database for the identification of non-synonymous coding SNPs with the potential to impact disease</article-title>. <source>Nucleic Acids Res</source> <volume>35</volume>: <fpage>D700</fpage>–<lpage>706</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Hijikata1"><label>97</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hijikata</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Raju</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Keerthikumar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ramabadran</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Balakrishnan</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Mutation@A Glance: an integrative web application for analysing mutations from human genetic diseases</article-title>. <source>DNA Res</source> <volume>17</volume>: <fpage>197</fpage>–<lpage>208</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Peterson1"><label>98</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peterson</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Adadey</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Santana-Cruz</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Winder</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>DMDM: domain mapping of disease mutations</article-title>. <source>Bioinformatics</source> <volume>26</volume>: <fpage>2458</fpage>–<lpage>2459</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Bromberg1"><label>99</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bromberg</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Rost</surname><given-names>B</given-names></name> (<year>2007</year>) <article-title>SNAP: predict effect of non-synonymous polymorphisms on function</article-title>. <source>Nucleic Acids Res</source> <volume>35</volume>: <fpage>3823</fpage>–<lpage>3835</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Bromberg2"><label>100</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bromberg</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yachdav</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rost</surname><given-names>B</given-names></name> (<year>2008</year>) <article-title>SNAP predicts effect of mutations on protein function</article-title>. <source>Bioinformatics</source> <volume>24</volume>: <fpage>2397</fpage>–<lpage>2398</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Kumar1"><label>101</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kumar</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Henikoff</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>PC</given-names></name> (<year>2009</year>) <article-title>Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm</article-title>. <source>Nat Protoc</source> <volume>4</volume>: <fpage>1073</fpage>–<lpage>1081</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Ng2"><label>102</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ng</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Henikoff</surname><given-names>S</given-names></name> (<year>2003</year>) <article-title>SIFT: Predicting amino acid changes that affect protein function</article-title>. <source>Nucleic Acids Res</source> <volume>31</volume>: <fpage>3812</fpage>–<lpage>3814</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Ramensky1"><label>103</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ramensky</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Bork</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sunyaev</surname><given-names>S</given-names></name> (<year>2002</year>) <article-title>Human non-synonymous SNPs: server and survey</article-title>. <source>Nucleic Acids Res</source> <volume>30</volume>: <fpage>3894</fpage>–<lpage>3900</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Adzhubei1"><label>104</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adzhubei</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Peshkin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ramensky</surname><given-names>VE</given-names></name>, <name name-style="western"><surname>Gerasimova</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>A method and server for predicting damaging missense mutations</article-title>. <source>Nat Methods</source> <volume>7</volume>: <fpage>248</fpage>–<lpage>249</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Capriotti1"><label>105</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Capriotti</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Calabrese</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Casadio</surname><given-names>R</given-names></name> (<year>2006</year>) <article-title>Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information</article-title>. <source>Bioinformatics</source> <volume>22</volume>: <fpage>2729</fpage>–<lpage>2734</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Yue1"><label>106</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yue</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Melamud</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Moult</surname><given-names>J</given-names></name> (<year>2006</year>) <article-title>SNPs3D: candidate gene and SNP selection for association studies</article-title>. <source>BMC Bioinformatics</source> <volume>7</volume>: <fpage>166</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Chelala1"><label>107</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chelala</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lemoine</surname><given-names>NR</given-names></name> (<year>2009</year>) <article-title>SNPnexus: a web database for functional annotation of newly discovered and public domain single nucleotide polymorphisms</article-title>. <source>Bioinformatics</source> <volume>25</volume>: <fpage>655</fpage>–<lpage>661</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-McLaren1"><label>108</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McLaren</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Pritchard</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Rios</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Flicek</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor</article-title>. <source>Bioinformatics</source> <volume>26</volume>: <fpage>2069</fpage>–<lpage>2070</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Becker1"><label>109</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Becker</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Barnes</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Bright</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>SA</given-names></name> (<year>2004</year>) <article-title>The genetic association database</article-title>. <source>Nat Genet</source> <volume>36</volume>: <fpage>431</fpage>–<lpage>432</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Forbes1"><label>110</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Forbes</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Bindal</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bamford</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cole</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kok</surname><given-names>CY</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer</article-title>. <source>Nucleic Acids Res</source> <volume>39</volume>: <fpage>D945</fpage>–<lpage>950</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Kawabata1"><label>111</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawabata</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ota</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nishikawa</surname><given-names>K</given-names></name> (<year>1999</year>) <article-title>The Protein Mutant Database</article-title>. <source>Nucleic Acids Res</source> <volume>27</volume>: <fpage>355</fpage>–<lpage>357</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Mitchell1"><label>112</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mitchell</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Aronson</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Mork</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Folk</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Humphrey</surname><given-names>SM</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Gene indexing: characterization and analysis of NLM's GeneRIFs</article-title>. <source>AMIA Annu Symp Proc</source> <fpage>460</fpage>–<lpage>464</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Hirschman1"><label>113</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hirschman</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yeh</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Blaschke</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Valencia</surname><given-names>A</given-names></name> (<year>2005</year>) <article-title>Overview of BioCreAtIvE: critical assessment of information extraction for biology</article-title>. <source>BMC Bioinformatics</source> <volume>6 Suppl 1</volume>: <fpage>S1</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Altman1"><label>114</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Altman</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Bergman</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Blake</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Blaschke</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Text mining for biology–the way forward: opinions from leading scientists</article-title>. <source>Genome Biol</source> <volume>9 Suppl 2</volume>: <fpage>S7</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Blaschke1"><label>115</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blaschke</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Andrade</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Ouzounis</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Valencia</surname><given-names>A</given-names></name> (<year>1999</year>) <article-title>Automatic extraction of biological information from scientific text: protein-protein interactions</article-title>. <source>Proc Int Conf Intell Syst Mol Biol</source> <fpage>60</fpage>–<lpage>67</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Laurila1"><label>116</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Laurila</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Naderi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Witte</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Riazanov</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kouznetsov</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Algorithms and semantic infrastructure for mutation impact extraction and grounding</article-title>. <source>BMC Genomics</source> <volume>11 Suppl 4</volume>: <fpage>S24</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Caporaso1"><label>117</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Caporaso</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Baumgartner</surname><given-names>WA</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Randolph</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Hunter</surname><given-names>L</given-names></name> (<year>2007</year>) <article-title>MutationFinder: a high-performance system for extracting point mutation mentions from text</article-title>. <source>Bioinformatics</source> <volume>23</volume>: <fpage>1862</fpage>–<lpage>1865</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Mika1"><label>118</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mika</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rost</surname><given-names>B</given-names></name> (<year>2004</year>) <article-title>NLProt: extracting protein names and sequences from papers</article-title>. <source>Nucleic Acids Res</source> <volume>32</volume>: <fpage>W634</fpage>–<lpage>637</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Hoffmann1"><label>119</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hoffmann</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Valencia</surname><given-names>A</given-names></name> (<year>2004</year>) <article-title>A gene network for navigating the literature</article-title>. <source>Nat Genet</source> <volume>36</volume>: <fpage>664</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Thornblad1"><label>120</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thornblad</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Elliott</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Jowett</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Visscher</surname><given-names>PM</given-names></name> (<year>2007</year>) <article-title>Prioritization of positional candidate genes using multiple web-based software tools</article-title>. <source>Twin Res Hum Genet</source> <volume>10</volume>: <fpage>861</fpage>–<lpage>870</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Seelow1"><label>121</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Seelow</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Schwarz</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Schuelke</surname><given-names>M</given-names></name> (<year>2008</year>) <article-title>GeneDistiller–distilling candidate genes from linkage intervals</article-title>. <source>PLoS ONE</source> <volume>3</volume>: <fpage>e3874</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0003874" xlink:type="simple">10.1371/journal.pone.0003874</ext-link></comment>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Aerts1"><label>122</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aerts</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lambrechts</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Maity</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Van Loo</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Coessens</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Gene prioritization through genomic data fusion</article-title>. <source>Nat Biotechnol</source> <volume>24</volume>: <fpage>537</fpage>–<lpage>544</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Cheng1"><label>123</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cheng</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Knox</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Stothard</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Damaraju</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>PolySearch: a web-based text mining system for extracting relationships between human diseases, genes, mutations, drugs and metabolites</article-title>. <source>Nucleic Acids Res</source> <volume>36</volume>: <fpage>W399</fpage>–<lpage>405</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Tranchevent3"><label>124</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tranchevent</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Capdevila</surname><given-names>FB</given-names></name>, <name name-style="western"><surname>Nitsch</surname><given-names>D</given-names></name>, <name name-style="western"><surname>De Moor</surname><given-names>B</given-names></name>, <name name-style="western"><surname>De Causmaecker</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>A guide to web tools to prioritize candidate genes</article-title>. <source>Briefings in bioinformatics</source> <volume>12</volume>: <fpage>22</fpage>–<lpage>32</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Yu2"><label>125</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wulf</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Khoury</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Gwinn</surname><given-names>M</given-names></name> (<year>2008</year>) <article-title>Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases</article-title>. <source>BMC Bioinformatics</source> <volume>9</volume>: <fpage>528</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Chen3"><label>126</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bardes</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Aronow</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Jegga</surname><given-names>AG</given-names></name> (<year>2009</year>) <article-title>ToppGene Suite for gene list enrichment analysis and candidate gene prioritization</article-title>. <source>Nucleic Acids Res</source> <volume>37</volume>: <fpage>W305</fpage>–<lpage>311</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Chen4"><label>127</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Aronow</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Jegga</surname><given-names>AG</given-names></name> (<year>2007</year>) <article-title>Improved human disease candidate gene prioritization using mouse phenotype</article-title>. <source>BMC Bioinformatics</source> <volume>8</volume>: <fpage>392</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Nilsson1"><label>128</label>
<mixed-citation publication-type="book" xlink:type="simple">Nilsson N (1997) Artificial Intelligence: A New Synthesis. San Francisco: Morgan Kaufmann Publishers. 513 p.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Bouckaert1"><label>129</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bouckaert</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Frank</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pfahringer</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>WEKA-experiences with a java open-source project</article-title>. <source>Journal of Machine Learning Research</source> <volume>11</volume>: <fpage>2533</fpage>–<lpage>2541</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Frank1"><label>130</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Frank</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Trigg</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Witten</surname><given-names>IH</given-names></name> (<year>2004</year>) <article-title>Data mining in bioinformatics using Weka</article-title>. <source>Bioinformatics</source> <volume>20</volume>: <fpage>2479</fpage>–<lpage>2481</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Gewehr1"><label>131</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gewehr</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Szugat</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zimmer</surname><given-names>R</given-names></name> (<year>2007</year>) <article-title>BioWeka–extending the Weka framework for bioinformatics</article-title>. <source>Bioinformatics</source> <volume>23</volume>: <fpage>651</fpage>–<lpage>653</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Steeb1"><label>132</label>
<mixed-citation publication-type="book" xlink:type="simple">Steeb W-H (2008) The nonlinear workbook: chaos, fractals, cellular automata, neural networks, genetic algorithms, gene expression programming, support vector machine, wavelets, hidden Markov models, fuzzy logic with C++, Java and symbolic C++ programs. 4th edition. Singapore: World Scientific Publishing. 628 p.</mixed-citation>
</ref>
<ref id="pcbi.1002902-BenGal1"><label>133</label>
<mixed-citation publication-type="book" xlink:type="simple">Ben-Gal I (2007) Bayesian networks. In: Ruggeri F, Kennett R, Faltin F, editors. Encyclopedia of statistics in quality and reliability. Chichester, England: John Wiley and Sons.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Habra1"><label>134</label>
<mixed-citation publication-type="other" xlink:type="simple">Habra A (2005) neural networks - an introduction. Available: <ext-link ext-link-type="uri" xlink:href="http://www.tek271.com/documents/others/into-to-neural-networks" xlink:type="simple">http://www.tek271.com/documents/others/into-to-neural-networks</ext-link>. Accessed 16 January 2013.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Sarasin1"><label>135</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sarasin</surname><given-names>A</given-names></name> (<year>2003</year>) <article-title>An overview of the mechanisms of mutagenesis and carcinogenesis</article-title>. <source>Mutat Res</source> <volume>544</volume>: <fpage>99</fpage>–<lpage>106</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Parsonnet1"><label>136</label>
<mixed-citation publication-type="book" xlink:type="simple">Parsonnet J (1999) Microbes and malignancy : infection as a cause of human cancers. New York: Oxford University Press. xii, 465 p.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Hitchins1"><label>137</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hitchins</surname><given-names>MP</given-names></name> (<year>2010</year>) <article-title>Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility</article-title>. <source>Adv Genet</source> <volume>70</volume>: <fpage>201</fpage>–<lpage>243</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Williams1"><label>138</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Williams</surname><given-names>D</given-names></name> (<year>2008</year>) <article-title>Radiation carcinogenesis: lessons from Chernobyl</article-title>. <source>Oncogene</source> <volume>27 Suppl 2</volume>: <fpage>S9</fpage>–<lpage>18</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Hall1"><label>139</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hall</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Frank</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pfahringer</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Reutemann</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>The WEKA Data Mining Software: an update</article-title>. <source>SIGKDD Explorations</source> <volume>11</volume>: <fpage>10</fpage>–<lpage>18</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Gaulton1"><label>140</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gaulton</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Mohlke</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Vision</surname><given-names>TJ</given-names></name> (<year>2007</year>) <article-title>A computational system to select candidate genes for complex human traits</article-title>. <source>Bioinformatics</source> <volume>23</volume>: <fpage>1132</fpage>–<lpage>1140</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Hutz1"><label>141</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hutz</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Kraja</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>McLeod</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Province</surname><given-names>MA</given-names></name> (<year>2008</year>) <article-title>CANDID: a flexible method for prioritizing candidate genes for complex human traits</article-title>. <source>Genet Epidemiol</source> <volume>32</volume>: <fpage>779</fpage>–<lpage>790</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-George1"><label>142</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>George</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Bryson-Richardson</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Fatkin</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Analysis of protein sequence and interaction data for candidate disease gene prediction</article-title>. <source>Nucleic Acids Res</source> <volume>34</volume>: <fpage>e130</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Xiong1"><label>143</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xiong</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>W</given-names></name> (<year>2008</year>) <article-title>PGMapper: a web-based tool linking phenotype to genes</article-title>. <source>Bioinformatics</source> <volume>24</volume>: <fpage>1011</fpage>–<lpage>1013</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Vanunu1"><label>144</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vanunu</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Magger</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Ruppin</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Shlomi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sharan</surname><given-names>R</given-names></name> (<year>2010</year>) <article-title>Associating genes and protein complexes with disease via network propagation</article-title>. <source>PLoS Comput Biol</source> <volume>6</volume>: <fpage>e1000641</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pcbi.1000641" xlink:type="simple">10.1371/journal.pcbi.1000641</ext-link></comment>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Franke1"><label>145</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Franke</surname><given-names>L</given-names></name>, <name name-style="western"><surname>van Bakel</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fokkens</surname><given-names>L</given-names></name>, <name name-style="western"><surname>de Jong</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Egmont-Petersen</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes</article-title>. <source>Am J Hum Genet</source> <volume>78</volume>: <fpage>1011</fpage>–<lpage>1025</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Adie2"><label>146</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adie</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Porteous</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Pickard</surname><given-names>BS</given-names></name> (<year>2006</year>) <article-title>SUSPECTS: enabling fast and effective prioritization of positional candidates</article-title>. <source>Bioinformatics</source> <volume>22</volume>: <fpage>773</fpage>–<lpage>774</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Murzin1"><label>147</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Murzin</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Brenner</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Hubbard</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Chothia</surname><given-names>C</given-names></name> (<year>1995</year>) <article-title>SCOP: a structural classification of proteins database for the investigation of sequences and structures</article-title>. <source>J Mol Biol</source> <volume>247</volume>: <fpage>536</fpage>–<lpage>540</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Finn1"><label>148</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Finn</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Mistry</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Tate</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Coggill</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Heger</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>The Pfam protein families database</article-title>. <source>Nucleic Acids Res</source> <volume>38</volume>: <fpage>D211</fpage>–<lpage>222</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Bateman1"><label>149</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bateman</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Birney</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Durbin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Eddy</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Howe</surname><given-names>KL</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>The Pfam protein families database</article-title>. <source>Nucleic Acids Res</source> <volume>28</volume>: <fpage>263</fpage>–<lpage>266</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Sigrist1"><label>150</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sigrist</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Cerutti</surname><given-names>L</given-names></name>, <name name-style="western"><surname>de Castro</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Langendijk-Genevaux</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Bulliard</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>PROSITE, a protein domain database for functional characterization and annotation</article-title>. <source>Nucleic Acids Res</source> <volume>38</volume>: <fpage>D161</fpage>–<lpage>166</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Maglott1"><label>151</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maglott</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ostell</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pruitt</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Tatusova</surname><given-names>T</given-names></name> (<year>2011</year>) <article-title>Entrez Gene: gene-centered information at NCBI</article-title>. <source>Nucleic Acids Res</source> <volume>39</volume>: <fpage>D52</fpage>–<lpage>57</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Flicek1"><label>152</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Flicek</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Amode</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Barrell</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Beal</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Brent</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Ensembl 2011</article-title>. <source>Nucleic Acids Res</source> <volume>39</volume>: <fpage>D800</fpage>–<lpage>806</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Hunter1"><label>153</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hunter</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Apweiler</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Attwood</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Bairoch</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bateman</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>InterPro: the integrative protein signature database</article-title>. <source>Nucleic Acids Res</source> <volume>37</volume>: <fpage>D211</fpage>–<lpage>215</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Rastogi1"><label>154</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rastogi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rost</surname><given-names>B</given-names></name> (<year>2011</year>) <article-title>LocDB: experimental annotations of localization for Homo sapiens and Arabidopsis thaliana</article-title>. <source>Nucleic Acids Res</source> <volume>39</volume>: <fpage>D230</fpage>–<lpage>234</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Rebhan1"><label>155</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rebhan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chalifa-Caspi</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Prilusky</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lancet</surname><given-names>D</given-names></name> (<year>1997</year>) <article-title>GeneCards: integrating information about genes, proteins and diseases</article-title>. <source>Trends Genet</source> <volume>13</volume>: <fpage>163</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Rost1"><label>156</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rost</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Yachdav</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name> (<year>2004</year>) <article-title>The PredictProtein server</article-title>. <source>Nucleic Acids Res</source> <volume>32</volume>: <fpage>W321</fpage>–<lpage>326</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Schlicker2"><label>157</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schlicker</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lengauer</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Albrecht</surname><given-names>M</given-names></name> (<year>2010</year>) <article-title>Improving disease gene prioritization using the semantic similarity of Gene Ontology terms</article-title>. <source>Bioinformatics</source> <volume>26</volume>: <fpage>i561</fpage>–<lpage>567</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-vanDriel1"><label>158</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Driel</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Bruggeman</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Vriend</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Brunner</surname><given-names>HG</given-names></name>, <name name-style="western"><surname>Leunissen</surname><given-names>JA</given-names></name> (<year>2006</year>) <article-title>A text-mining analysis of the human phenome</article-title>. <source>Eur J Hum Genet</source> <volume>14</volume>: <fpage>535</fpage>–<lpage>542</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Radivojac1"><label>159</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Radivojac</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>WT</given-names></name>, <name name-style="western"><surname>Peters</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Mohan</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>An integrated approach to inferring gene-disease associations in humans</article-title>. <source>Proteins</source> <volume>72</volume>: <fpage>1030</fpage>–<lpage>1037</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Kanehisa1"><label>160</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kanehisa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Goto</surname><given-names>S</given-names></name> (<year>2000</year>) <article-title>KEGG: kyoto encyclopedia of genes and genomes</article-title>. <source>Nucleic Acids Res</source> <volume>28</volume>: <fpage>27</fpage>–<lpage>30</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Kanehisa2"><label>161</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kanehisa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Goto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Furumichi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tanabe</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hirakawa</surname><given-names>M</given-names></name> (<year>2010</year>) <article-title>KEGG for representation and analysis of molecular networks involving diseases and drugs</article-title>. <source>Nucleic Acids Res</source> <volume>38</volume>: <fpage>D355</fpage>–<lpage>360</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-DEustachio1"><label>162</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>D'Eustachio</surname><given-names>P</given-names></name> (<year>2011</year>) <article-title>Reactome knowledgebase of human biological pathways and processes</article-title>. <source>Methods Mol Biol</source> <volume>694</volume>: <fpage>49</fpage>–<lpage>61</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Matthews1"><label>163</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matthews</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gopinath</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gillespie</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Caudy</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Croft</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Reactome knowledgebase of human biological pathways and processes</article-title>. <source>Nucleic Acids Res</source> <volume>37</volume>: <fpage>D619</fpage>–<lpage>622</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Xenarios1"><label>164</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xenarios</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Salwinski</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Duan</surname><given-names>XJ</given-names></name>, <name name-style="western"><surname>Higney</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SM</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions</article-title>. <source>Nucleic Acids Res</source> <volume>30</volume>: <fpage>303</fpage>–<lpage>305</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Stark1"><label>165</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stark</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Breitkreutz</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Chatr-Aryamontri</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Boucher</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Oughtred</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The BioGRID Interaction Database: 2011 update</article-title>. <source>Nucleic Acids Res</source> <volume>39</volume>: <fpage>D698</fpage>–<lpage>704</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Barrett1"><label>166</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barrett</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Troup</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Wilhite</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Ledoux</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Evangelista</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>NCBI GEO: archive for functional genomics data sets–10 years on</article-title>. <source>Nucleic Acids Res</source> <volume>39</volume>: <fpage>D1005</fpage>–<lpage>1010</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Edgar1"><label>167</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Edgar</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Domrachev</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lash</surname><given-names>AE</given-names></name> (<year>2002</year>) <article-title>Gene Expression Omnibus: NCBI gene expression and hybridization array data repository</article-title>. <source>Nucleic Acids Res</source> <volume>30</volume>: <fpage>207</fpage>–<lpage>210</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Parkinson1"><label>168</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Parkinson</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sarkans</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Kolesnikov</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Abeygunawardena</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Burdett</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>ArrayExpress update–an archive of microarray and high-throughput sequencing-based functional genomics experiments</article-title>. <source>Nucleic Acids Res</source> <volume>39</volume>: <fpage>D1002</fpage>–<lpage>1004</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Iacucci1"><label>169</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iacucci</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Tranchevent</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Popovic</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Pavlopoulos</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>De Moor</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>ReLiance: a machine learning and literature-based prioritization of receptor–ligand pairings</article-title>. <source>Bioinformatics</source> <volume>28</volume>: <fpage>i569</fpage>–<lpage>i574</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Navlakha1"><label>170</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Navlakha</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kingsford</surname><given-names>C</given-names></name> (<year>2010</year>) <article-title>The power of protein interaction networks for associating genes with diseases</article-title>. <source>Bioinformatics</source> <volume>26</volume>: <fpage>1057</fpage>–<lpage>1063</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Ostlund1"><label>171</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ostlund</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lindskog</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sonnhammer</surname><given-names>EL</given-names></name> (<year>2010</year>) <article-title>Network-based Identification of novel cancer genes</article-title>. <source>Mol Cell Proteomics</source> <volume>9</volume>: <fpage>648</fpage>–<lpage>655</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-OBrien1"><label>172</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>O'Brien</surname><given-names>KP</given-names></name>, <name name-style="western"><surname>Westerlund</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Sonnhammer</surname><given-names>EL</given-names></name> (<year>2004</year>) <article-title>OrthoDisease: a database of human disease orthologs</article-title>. <source>Hum Mutat</source> <volume>24</volume>: <fpage>112</fpage>–<lpage>119</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Li1"><label>173</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Stoeckert</surname><given-names>CJ</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Roos</surname><given-names>DS</given-names></name> (<year>2003</year>) <article-title>OrthoMCL: identification of ortholog groups for eukaryotic genomes</article-title>. <source>Genome Res</source> <volume>13</volume>: <fpage>2178</fpage>–<lpage>2189</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Bult1"><label>174</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bult</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Eppig</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Kadin</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Blake</surname><given-names>JA</given-names></name> (<year>2008</year>) <article-title>The Mouse Genome Database (MGD): mouse biology and model systems</article-title>. <source>Nucleic Acids Res</source> <volume>36</volume>: <fpage>D724</fpage>–<lpage>728</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Schofield1"><label>175</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schofield</surname><given-names>PN</given-names></name>, <name name-style="western"><surname>Gruenberger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sundberg</surname><given-names>JP</given-names></name> (<year>2010</year>) <article-title>Pathbase and the MPATH ontology: community resources for mouse histopathology</article-title>. <source>Vet Pathol</source> <volume>47</volume>: <fpage>1016</fpage>–<lpage>1020</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Osborne1"><label>176</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Osborne</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kibbe</surname><given-names>WA</given-names></name> (<year>2007</year>) <article-title>Mining biomedical data using MetaMap Transfer (MMtx) and the Unified Medical Language System (UMLS)</article-title>. <source>Methods Mol Biol</source> <volume>408</volume>: <fpage>153</fpage>–<lpage>169</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Smith2"><label>177</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Eppig</surname><given-names>JT</given-names></name> (<year>2009</year>) <article-title>The mammalian phenotype ontology: enabling robust annotation and comparative analysis</article-title>. <source>Wiley Interdiscip Rev Syst Biol Med</source> <volume>1</volume>: <fpage>390</fpage>–<lpage>399</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Smith3"><label>178</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Goldsmith</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Eppig</surname><given-names>JT</given-names></name> (<year>2005</year>) <article-title>The Mammalian Phenotype Ontology as a tool for annotating, analyzing and comparing phenotypic information</article-title>. <source>Genome Biol</source> <volume>6</volume>: <fpage>R7</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Robinson1"><label>179</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Robinson</surname><given-names>PN</given-names></name>, <name name-style="western"><surname>Kohler</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bauer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Seelow</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Horn</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease</article-title>. <source>Am J Hum Genet</source> <volume>83</volume>: <fpage>610</fpage>–<lpage>615</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Kelso1"><label>180</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kelso</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Visagie</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Theiler</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Christoffels</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bardien</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>eVOC: a controlled vocabulary for unifying gene expression data</article-title>. <source>Genome Res</source> <volume>13</volume>: <fpage>1222</fpage>–<lpage>1230</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1002902-Stenson1"><label>181</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stenson</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Ball</surname><given-names>EV</given-names></name>, <name name-style="western"><surname>Mort</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Shiel</surname><given-names>JA</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Human Gene Mutation Database (HGMD): 2003 update</article-title>. <source>Hum Mutat</source> <volume>21</volume>: <fpage>577</fpage>–<lpage>581</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>